cartilage disease: Softening and degeneration of the CARTILAGE. Pathological processes involving the chondral tissue (CARTILAGE).
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
950 |
4. Check minimum number of eventsNone |
950 |
5. Include endpointsNone |
950 |
6. Filter based on genotype QC (FinnGen only) |
930 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M24
- Name in latin
- Alia vitia cartilaginum articularium
Similar endpoints
↥List of similar endpoints to
Other articular cartilage disorders
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7026 | 3215 | 3754 |
| Only index persons | 6071 | 2847 | 3224 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.09 | 0.10 |
| Only index persons | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 37.19 | 39.65 | 34.93 |
| Only index persons | 35.55 | 37.92 | 33.46 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 930 | 455 | 475 |
| Unadjusted period prevalence (%) | 0.19 | 0.16 | 0.22 |
| Median age at first event (years) | 35.29 | 34.33 | 36.22 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 950
- Matched controls
- 9500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M24.1
ICD-10 Finland
Other articular cartilage disorders
+∞
307.7
302
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
28.6
307.7
345
186
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
22.4
302.1
240
141
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
54.0
280.2
162
36
1220
FHL
Arthroscopy
45.8
277.5
167
44
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
80.6
257.7
138
20
72498
ICD-8 Finland
Internal derangement of joint, Alio loco definito
+∞
232.1
213
*
72499
ICD-8 Finland
Internal derangement of joint, Derangement of other joints
+∞
224.1
206
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
22.2
203.7
157
84
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
194.7
180
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
17.5
188.9
164
112
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
38.0
186.5
117
35
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
14.0
183.6
183
159
7180F
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,POLVI]
+∞
182.3
169
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
22.2
165.4
126
65
M01AX05
ATC
glucosamine; oral
6.8
133.6
250
472
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
70.7
132.0
72
11
M09AX01
ATC
hyaluronic acid; parenteral
22.8
124.8
93
45
1221
FHL
Arthroscopy and meniscus surgery
48.9
109.4
64
14
1223
FHL
Arthroscopy and articular cartilage surgery
1139.7
106.5
102
*
M25.5
ICD-10 Finland
Pain in joint
4.4
104.3
379
1239
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
+∞
104.1
98
*
L90
ICPC
Osteoarthrosis of knee
13.7
103.3
100
81
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
186.0
97.3
100
6
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
53.0
95.7
55
11
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
41.6
90.6
55
14
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
6.7
88.7
156
271
M20.1
ICD-10 Finland
Hallux valgus (acquired)
15.4
87.0
78
55
M13.9
ICD-10 Finland
Arthritis, unspecified
13.5
84.8
82
66
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
80.4
76
*
N02AX02
ATC
tramadol; systemic, rectal
3.5
80.2
524
2454
1225
FHL
Arthroscopy and other therapeutic procedure
39.7
79.7
49
13
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
8.2
76.5
108
147
WX320
NOMESCO Finland
Spinalanesthesy
4.1
75.1
262
808
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
14.5
74.8
69
51
L15
ICPC
Knee symptom/complaint
3.8
70.1
276
922
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
17.6
69.9
58
35
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
27.4
68.4
47
18
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
14.3
67.9
63
47
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.2
67.7
494
2404
M22.4
ICD-10 Finland
Chondromalacia patellae
125.8
65.8
70
6
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
84.0
63.0
70
9
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
8.8
61.5
80
98
M23.8
ICD-10 Finland
Other internal derangements of knee
16.0
60.9
53
35
M01AH01
ATC
celecoxib; oral
3.9
60.9
216
666
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
6.3
56.7
102
179
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.2
56.2
307
1239
M01AH05
ATC
etoricoxib; oral
3.0
55.1
648
3949
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
5.3
54.6
119
250
L04AX03
ATC
methotrexate; systemic
6.9
51.9
84
132
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
50.5
48
*
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
49.4
47
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.0
49.3
92
167
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
5.0
48.2
111
244
B01AB05
ATC
enoxaparin; parenteral
2.8
45.8
320
1455
ZXA05
NOMESCO Finland
Left side
3.0
45.6
266
1098
N03AX12
ATC
[U] gabapentin; oral
3.4
45.5
192
655
B01AF01
ATC
rivaroxaban; oral
4.1
45.2
139
383
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
45.2
43
*
ZXA00
NOMESCO Finland
Right side
2.9
45.1
277
1175
M79.6
ICD-10 Finland
Pain in limb
2.6
44.8
449
2438
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
84.3
43.3
48
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
43.0
149
446
P01BA02
ATC
hydroxychloroquine; oral
7.7
42.4
61
84
N03AX16
ATC
[U] pregabalin
2.9
42.2
254
1062
S83.2
ICD-10 Finland
Tear of meniscus, current
5.2
39.8
87
182
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
10.0
39.7
46
48
N02AJ06
ATC
codeine and paracetamol; systemic
2.5
39.2
433
2419
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
208.5
39.1
40
*
84400
ICD-8 Finland
Sprains and strains of knee and leg
12.3
38.7
39
33
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.3
36.4
159
550
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
35.6
34
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
33.5
32
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
13.2
33.3
32
25
WX111
NOMESCO Finland
Local infiltration anesthesia
93.5
32.9
36
*
M10.9
ICD-10 Finland
Gout, unspecified
5.3
32.4
68
137
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
10.4
32.0
36
36
M01AC06
ATC
meloxicam; systemic, rectal
2.3
31.1
347
1904
N02BE01
ATC
paracetamol; systemic, rectal
3.7
30.6
871
7105
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
+∞
30.4
29
*
L89
ICPC
Osteoarthrosis of hip
11.4
30.4
32
29
S18
ICPC
Laceration/cut
2.2
30.3
464
2886
ACC51
NOMESCO Finland
Release of median nerve
3.9
29.4
93
259
L08
ICPC
Shoulder symptom/complaint
2.4
28.8
242
1168
L13
ICPC
Hip symptom/complaint
2.7
28.7
177
736
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.6
28.6
41
56
N06AA09
ATC
amitriptyline; systemic
3.4
28.3
110
352
N02BF01
ATC
gabapentin; oral
3.2
28.2
121
411
M01AB05
ATC
diclofenac; systemic, rectal
2.2
27.5
639
4604
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
6.0
27.0
49
86
M19.9
ICD-10 Finland
Arthrosis, unspecified
6.3
26.9
46
76
M17.5
ICD-10 Finland
Other secondary gonarthrosis
77.5
26.9
30
*
M02AA07
ATC
piroxicam; topical
2.2
26.9
343
1964
M03BX02
ATC
tizanidine; oral
2.1
26.9
614
4377
NFF25
NOMESCO Finland
Cleaning of hip joint, arthroscopic
278.6
26.9
27
*
X58
ICD-10 Finland
Exposure to other specified factors
2.7
26.8
164
678
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
26.7
112
375
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.2
26.6
73
183
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
26.4
197
897
1222
FHL
Arthroscopy and synovial surgery
+∞
26.2
25
*
NF1AA
NOMESCO Finland
Hip X-ray examination
4.2
26.0
72
182
M70.6
ICD-10 Finland
Trochanteric bursitis
3.0
25.9
130
483
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.0
25.8
76
201
H02AB06
ATC
prednisolone; systemic
2.1
25.8
449
2880
A07EC01
ATC
sulfasalazine; oral, rectal
5.2
25.6
54
109
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.8
25.5
81
226
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
51.5
25.4
30
6
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.7
25.1
158
661
B01AX06
ATC
[U] rivaroxaban
59.7
25.1
29
5
M01AX17
ATC
nimesulide; oral
2.3
24.9
235
1185
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
256.6
24.8
25
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
133.5
24.7
26
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
133.5
24.7
26
*
Z3226
NOMESCO Finland
Physiotherapist
2.5
24.3
176
788
L01BA01
ATC
methotrexate; systemic
30.0
24.2
32
11
A02BC02
ATC
pantoprazole; systemic
2.1
24.2
652
4852
M54.5
ICD-10 Finland
Low back pain
2.1
23.8
347
2070
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.5
23.5
85
259
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
8.6
23.2
30
36
N02AA05
ATC
oxycodone; systemic
2.4
23.2
190
898
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.5
23.2
83
251
N06AX21
ATC
duloxetine; oral
2.8
22.8
125
486
M19.2
ICD-10 Finland
Other secondary arthrosis
123.0
22.7
24
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
22.7
99
339
M01AB08
ATC
etodolac; oral
3.4
22.6
84
260
L17
ICPC
Foot/toe symptom/complaint
2.1
22.5
279
1563
R03AC02
ATC
salbutamol; inhalant
2.0
22.3
522
3650
M48.0
ICD-10 Finland
Spinal stenosis
2.8
22.3
120
462
M15
ICD-10 Finland
Polyarthrosis
5.2
22.3
47
95
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
21.8
350
2149
WX200
NOMESCO Finland
Interscalenous plexus blockade
7.3
21.7
32
45
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
21.5
118
459
M01AE02
ATC
naproxen; oral, rectal
1.9
21.5
515
3614
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.3
21.4
87
285
J01AA02
ATC
doxycycline; systemic
2.2
21.1
754
6054
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
4.1
20.8
58
147
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
20.8
76
233
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
3.8
20.6
66
185
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
20.6
368
2334
SPAT1153
SPAT
Removal of sutures
2.0
20.4
284
1650
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
4.1
20.4
57
145
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
20.2
337
2084
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
8.6
20.2
26
31
NG2AA
NOMESCO Finland
Patella X-ray examination
27.7
20.1
27
10
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
20.0
328
2015
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
+∞
19.9
19
*
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
5.0
19.8
43
89
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
75.1
19.8
22
*
A02BC05
ATC
esomeprazole; systemic
1.9
19.8
381
2469
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
29.6
19.7
26
9
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
19.5
241
1337
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
32.0
19.3
25
8
L88
ICPC
Rheumatoid/seropositive arthritis
17.2
19.3
30
18
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
5.4
19.0
38
73
L40.5
ICD-10 Finland
Arthropathic psoriasis
56.2
19.0
22
*
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
+∞
18.8
18
*
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
18.8
18
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
18.8
18
*
9243
FHL
Plastic of the patella and its tendons
28.5
18.8
25
9
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
71.4
18.8
21
*
NG1AA, ,
SPAT
3.0
18.6
85
298
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
3.7
18.6
60
169
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
18.4
291
1757
RF210, ,
NOMESCO Finland
6.8
18.4
29
44
M25.2
ICD-10 Finland
Flail joint
44.9
18.3
22
5
NG1DA
NOMESCO Finland
X-ray of knees
53.6
18.0
21
*
M01AE11
ATC
tiaprofenic acid; oral, rectal
4.6
17.9
43
97
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.5
17.8
62
184
L04AA13
ATC
[U] leflunomide
67.9
17.8
20
*
J01DB01
ATC
cefalexin; oral
2.1
17.8
767
6342
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
17.7
187
974
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
17.5
177
906
R4110
NOMESCO Finland
Physiotherapy
2.0
17.5
260
1534
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
5.0
17.4
38
79
L20
ICPC
Joint symptom/complaint NOS
5.0
17.4
38
79
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
17.4
78
271
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
17.3
110
459
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
17.8
17.0
26
15
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.4
16.8
63
196
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
64.5
16.8
19
*
SPAT1202
SPAT
Intra-articular injection
6.6
16.7
27
42
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
+∞
16.7
16
*
9271
FHL
Hallux surgery
+∞
16.7
16
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
+∞
16.7
16
*
7180A
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,OLKANIVEL]
+∞
16.7
16
*
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
16.7
180
944
L28
ICPC
Limited function/disability (L)
2.2
16.6
159
795
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
91.7
16.6
18
*
L12
ICPC
Hand/finger symptom/complaint
2.2
16.6
158
789
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
18.3
16.5
25
14
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.7
16.5
93
366
A02BC01
ATC
omeprazole; systemic
1.9
16.5
245
1442
S83.5
ICD-10 Finland
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
4.3
16.4
42
100
G56.2
ICD-10 Finland
Lesion of ulnar nerve
3.9
16.3
48
127
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
21.4
16.0
23
11
NGE35
NOMESCO Finland
Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic
5.6
15.8
30
55
M02AA10
ATC
ketoprofen; topical
2.2
15.8
150
748
72490, ,
ICD-8 Finland
+∞
15.7
15
*
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
5.7
15.6
29
52
NGF40
NOMESCO Finland
Repair of defect of cartilage in the knee joint with transplant
162.6
15.5
16
*
R4120
NOMESCO Finland
Occupational therapy
3.1
15.5
68
233
NBG10
NOMESCO Finland
Acromioplastia
5.9
15.5
28
49
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
15.3
173
922
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.9
15.3
34
72
L29
ICPC
Musculoskeletal sympt/complt other
2.7
15.3
85
332
L16
ICPC
Ankle symptom/complaint
2.5
15.2
106
462
M20.2
ICD-10 Finland
Hallux rigidus
18.1
15.2
23
13
S43.0
ICD-10 Finland
Dislocation of shoulder joint
3.8
15.2
46
124
72908
ICD-8 Finland
Other diseases of joint, Alii definiti
23.8
15.1
21
9
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
45.8
15.1
18
*
D07AC01
ATC
betamethasone; topical
1.8
15.1
335
2225
1224
FHL
Arthroscopy and loose removal
57.6
14.8
17
*
R03DC03
ATC
montelukast; oral
2.1
14.7
156
811
J01DA01
ATC
[U] cefalexin
1.7
14.7
560
4315
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
14.6
652
5244
NHG82
NOMESCO Finland
Fusion of other tarsal joint
+∞
14.6
14
*
212
Kela drug reimbursment
Gout
+∞
14.6
14
*
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
6.5
14.6
24
38
NGF20
NOMESCO Finland
Operation for osteochondritis of knee, open
81.4
14.6
16
*
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
4.8
14.6
33
71
M01AH02
ATC
rofecoxib; oral
2.4
14.3
101
442
M24.2
ICD-10 Finland
Disorder of ligament
27.6
14.3
19
7
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
10.7
14.3
27
26
Z50.1
ICD-10 Finland
Other physical therapy
3.3
14.1
53
165
M04AA01
ATC
allopurinol; systemic
2.4
13.8
105
475
G47.3
ICD-10 Finland
Sleep apnoea
1.9
13.8
223
1338
M93.2
ICD-10 Finland
Osteochondritis dissecans
54.2
13.8
16
*
M19.8
ICD-10 Finland
Other specified arthrosis
4.2
13.8
37
91
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.0
13.8
63
221
A01
ICPC
Pain general/multiple sites
2.5
13.8
93
399
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
13.8
200
1160
S80.0
ICD-10 Finland
Contusion of knee
2.7
13.6
74
285
WZA00
NOMESCO Finland
Concise certificate
3.2
13.6
54
174
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
76.3
13.6
15
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
13.6
13
*
7174A
ICD-9 Finland
Internal derangement of knee, Derangement of lateral meniscus
+∞
13.6
13
*
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
13.6
13
*
9241
FHL
Due to repeated dislocation of the shoulder joint plastic
+∞
13.6
13
*
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
13.6
13
*
M22.0
ICD-10 Finland
Recurrent dislocation of patella
+∞
13.6
13
*
M23.4
ICD-10 Finland
Loose body in knee
+∞
13.6
13
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
16.5
13.5
21
13
M25.0
ICD-10 Finland
Haemarthrosis
142.0
13.5
14
*
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
18.5
13.4
20
11
WZA90
NOMESCO Finland
Other medical or dental certificate
1.9
13.3
199
1164
M10.0
ICD-10 Finland
Idiopathic gout
5.4
13.3
26
49
M01AB55
ATC
diclofenac, combinations; oral
3.1
13.2
56
188
H02AB04
ATC
methylprednisolone; systemic
2.1
13.2
129
648
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.6
13.1
31
69
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
15.3
13.1
21
14
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.2
13.1
53
173
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
13.1
68
256
M79.1
ICD-10 Finland
Myalgia
2.1
13.1
134
686
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.3
12.9
49
154
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
3.4
12.9
46
139
M77.1
ICD-10 Finland
Lateral epicondylitis
2.6
12.9
80
330
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
50.7
12.9
15
*
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.2
12.8
51
165
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
10.7
12.8
24
23
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
10.7
12.8
24
23
R06AE07
ATC
cetirizine; oral
1.7
12.7
371
2629
M35.7
ICD-10 Finland
Hypermobility syndrome
15.7
12.6
20
13
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
12.6
277
1816
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
70.8
12.6
14
*
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
10.2
12.5
24
24
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
12.5
12
*
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
12.5
12
*
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
13.4
12.5
21
16
M07.3
ICD-10 Finland
Other psoriatic arthropathies
131.7
12.5
13
*
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
131.7
12.5
13
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
12.4
153
837
J04AB02
ATC
rifampicin; systemic
11.8
12.4
22
19
M54.3
ICD-10 Finland
Sciatica
2.8
12.2
61
225
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
12.2
425
3144
R06.0
ICD-10 Finland
Dyspnoea
1.8
12.0
235
1490
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
11.9
201
1217
N02BF02
ATC
pregabalin; oral
2.7
11.9
63
240
M79.7
ICD-10 Finland
Fibromyalgia
4.2
11.9
31
75
R20.2
ICD-10 Finland
Paraesthesia of skin
2.6
11.8
69
276
S70.0
ICD-10 Finland
Contusion of hip
3.5
11.8
41
122
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
11.7
203
1239
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
5.6
11.7
22
40
R05
ICD-10 Finland
Cough
1.8
11.7
189
1130
WZC30
NOMESCO Finland
Teaching
1.9
11.6
166
954
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
3.1
11.6
48
159
A02BC03
ATC
lansoprazole; oral
1.7
11.6
251
1634
L04AB01
ATC
etanercept; parenteral
23.2
11.6
16
7
M77.4
ICD-10 Finland
Metatarsalgia
2.9
11.6
54
192
J01FA10
ATC
azithromycin; systemic
1.6
11.5
499
3871
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
11.5
315
2182
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
+∞
11.5
11
*
7152F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, secondary[OSTEORTHROSIS SECUNDARIA,POLVI]
+∞
11.5
11
*
M22.1
ICD-10 Finland
Recurrent subluxation of patella
121.4
11.4
12
*
R01AD01
ATC
beclometasone; nasal
2.0
11.4
146
809
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
4.3
11.3
29
69
A02BA02
ATC
ranitidine; systemic
1.9
11.3
173
1015
R01AD09
ATC
mometasone; nasal
1.6
11.3
387
2835
RD211, ,
NOMESCO Finland
3.1
11.3
48
162
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
11.2
565
4532
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
11.2
122
637
R03AC03
ATC
terbutaline; inhalant
2.1
11.2
121
630
NF1DA
NOMESCO Finland
X-ray of hips
17.3
11.2
17
10
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
5.6
11.2
21
38
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
11.2
409
3040
ZXD20
NOMESCO Finland
Day surgery
2.1
11.0
106
529
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
11.0
823
7311
J01FA06
ATC
roxithromycin; oral
1.6
11.0
348
2497
TNG10
NOMESCO Finland
Puncture of knee
43.8
10.9
13
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
10.9
174
1034
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
10.9
79
350
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.9
10.9
50
176
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
5.2
10.8
22
43
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
10.8
233
1513
9255
FHL
Joint auger removal
28.4
10.7
14
5
M77.0
ICD-10 Finland
Medial epicondylitis
4.1
10.7
29
72
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
10.7
67
277
M24.8
ICD-10 Finland
Other specific joint derangements, not elsewhere classified
60.7
10.6
12
*
72221
ICD-8 Finland
Osteochondrosis, Dissecans
60.7
10.6
12
*
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.1
10.6
43
141
M15.8
ICD-10 Finland
Other polyarthrosis
9.3
10.5
21
23
NH1AD
NOMESCO Finland
Ankle and foot CT
4.7
10.5
24
52
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
10.5
197
1228
J01FF01
ATC
clindamycin; systemic
1.7
10.4
232
1516
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
111.2
10.4
11
*
M17.2
ICD-10 Finland
Post-traumatic gonarthrosis, bilateral
111.2
10.4
11
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
+∞
10.4
10
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
10.4
10
*
7180G
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,NILKKA]
+∞
10.4
10
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
+∞
10.4
10
*
NGC99
NOMESCO Finland
Other secondary prosthetic replacement inknee joint, other or unspecified
+∞
10.4
10
*
R60.0
ICD-10 Finland
Localized oedema
2.1
10.4
100
498
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
5.2
10.3
21
41
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
10.3
456
3524
XA402
NOMESCO Finland
ENMG
4.1
10.3
28
70
H02AB07
ATC
prednisone; oral
2.1
10.3
107
550
Z01.2
ICD-10 Finland
Dental examination
1.6
10.3
382
2836
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.2
10.2
92
447
M01AH03
ATC
valdecoxib; oral
2.7
10.1
56
218
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
10.1
195
1224
Z71.8
ICD-10 Finland
Other specified counselling
1.6
10.1
283
1962
L03
ICPC
Low back symptom/complaint
1.7
10.1
230
1512
S83.3
ICD-10 Finland
Tear of articular cartilage of knee, current
11.4
10.1
18
16
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.8
10.0
51
190
EC1VA, ,
NOMESCO Finland
2.9
9.9
47
169
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.9
185
1151
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
5.2
9.9
20
39
ZXE00
NOMESCO Finland
One hour or less
1.6
9.9
312
2225
S83.4
ICD-10 Finland
Sprain and strain involving (fibular)(tibial) collateral ligament of knee
3.9
9.8
29
77
S83.0
ICD-10 Finland
Dislocation of patella
10.8
9.8
18
17
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
7.5
9.7
22
30
Z3231
NOMESCO Finland
Registered nurse
1.7
9.6
234
1562
M54.2
ICD-10 Finland
Cervicalgia
2.3
9.6
71
318
M23.3
ICD-10 Finland
Other meniscus derangements
15.2
9.5
15
10
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
15.2
9.5
15
10
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
9.5
107
565
R50.9
ICD-10 Finland
Fever, unspecified
1.9
9.5
134
764
R52.9
ICD-10 Finland
Pain, unspecified
2.1
9.5
88
432
M01CB01
ATC
sodium aurothiomalate; parenteral
101.0
9.4
10
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
9.4
629
5283
7183A
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, OLKANIVEL]
+∞
9.4
9
*
7188E
ICD-9 Finland
Other derangement of joint, Other joint derangement, not elsewhere classified[MB ARTICULI, LIGAM ET CARTILAG AL DEF,LONKKANIVEL]
+∞
9.4
9
*
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
+∞
9.4
9
*
72904
ICD-8 Finland
Other diseases of joint, Dislocatio spontanea
+∞
9.4
9
*
NHG20
NOMESCO Finland
Fusion of talocrural joint
+∞
9.4
9
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
9.3
123
686
M01AB16
ATC
aceclofenac; oral
3.7
9.3
29
80
N04BC05
ATC
pramipexole; oral
2.3
9.3
73
335
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
9.3
71
322
N06AX16
ATC
venlafaxine; oral
1.9
9.3
123
688
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.5
9.3
31
90
H02BX01
ATC
methylprednisolone, combinations; systemic
2.9
9.2
43
153
TQW40, ,
SPAT
2.1
9.2
89
445
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
3.0
9.2
40
137
L14
ICPC
Leg/thigh symptom/complaint
2.3
9.2
69
311
NG1AD
NOMESCO Finland
Knee CT examination
7.8
9.2
20
26
R96
ICPC
Asthma
2.1
9.2
84
411
SFA10
NOMESCO Finland
One-surface restoration
1.5
9.1
471
3730
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.3
9.1
33
101
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
4.6
9.1
21
46
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
4.8
9.1
20
42
AA1AD
NOMESCO Finland
CT of head and brain
1.6
9.1
258
1788
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
15.8
9.0
14
9
R05
ICPC
Cough
1.7
9.0
209
1375
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.6
9.0
29
82
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.7
9.0
47
178
M01AC01
ATC
piroxicam; systemic, rectal
1.9
9.0
111
606
R52.2
ICD-10 Finland
Other chronic pain
3.3
9.0
34
107
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
24.3
8.9
12
5
UJF32
NOMESCO Finland
Coloscopy
1.6
8.9
219
1464
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.6
8.8
29
83
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
10.8
8.8
16
15
E883A
ICD-9 Finland
Fall into hole or other opening in surface
2.6
8.8
49
192
P06
ICPC
Sleep disturbance
2.0
8.8
106
574
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.8
241
1654
L91
ICPC
Osteoarthrosis other
7.3
8.8
20
28
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
8.7
83
412
R5110, ,
SPAT
2.3
8.7
69
318
M01AB01
ATC
indometacin; systemic, rectal
2.3
8.7
67
305
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.3
8.7
33
104
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
50.5
8.7
10
*
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
50.5
8.7
10
*
ZX140
NOMESCO Finland
Intra articular
50.5
8.7
10
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
8.7
118
665
RF410, ,
NOMESCO Finland
11.7
8.6
15
13
M65.3
ICD-10 Finland
Trigger finger
2.7
8.6
44
165
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.6
8.6
28
80
9244
FHL
Plastic or reconstruction of ligaments of the knee other than the lumbar region
16.5
8.6
13
8
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.1
8.5
82
409
G44.2
ICD-10 Finland
Tension-type headache
1.9
8.4
110
611
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.3
8.4
31
96
M01AE51
ATC
ibuprofen, combinations; systemic
4.9
8.4
18
37
NHG22
NOMESCO Finland
Fusion of subtalar joint
+∞
8.3
8
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
8.3
126
734
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
8.3
93
490
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
9.6
8.3
16
17
R52.1
ICD-10 Finland
Chronic intractable pain
9.6
8.3
16
17
RF420, ,
NOMESCO Finland
9.6
8.3
16
17
N02AC04
ATC
dextropropoxyphene; oral
3.0
8.3
35
118
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.8
8.3
42
157
B01AB04
ATC
dalteparin; parenteral
2.8
8.2
41
152
S83
ICD-10 Finland
Dislocation, sprain and strain of joints and ligaments of knee
4.6
8.1
19
42
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
3.5
8.1
27
78
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.3
8.1
58
256
NCF25
NOMESCO Finland
Operation for osteochondritis of elbow joint, arthroscopic
33.6
8.1
10
*
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
11.8
8.1
14
12
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
17.3
8.1
12
7
R03BA05
ATC
fluticasone; inhalant
1.7
8.1
152
944
J01FA09
ATC
clarithromycin; systemic
1.6
8.0
262
1866
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
22.2
8.0
11
5
N06AX11
ATC
mirtazapine; oral
1.5
8.0
289
2105
M01AX01
ATC
nabumetone; oral
3.0
8.0
34
115
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
7.9
246
1732
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
7.9
206
1391
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.9
188
1241
SFA20
NOMESCO Finland
Two-surface restoration
1.5
7.9
501
4090
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
7.9
206
1392
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
4.7
7.9
18
39
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.3
7.9
62
285
9057A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of sprain and strain without mention of tendon injury
13.2
7.9
13
10
NB1AD
NOMESCO Finland
Shoulder CT examination
6.2
7.9
20
33
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.9
148
919
S66.3
ICD-10 Finland
Injury of extensor muscle and tendon of other finger at wrist and hand level
3.8
7.8
23
61
84500
ICD-8 Finland
Sprains and strains of ankle and foot, Ankle
4.1
7.8
21
52
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.9
7.8
94
508
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
7.8
209
1422
A03
ICPC
Fever
1.7
7.8
140
858
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
3.7
7.8
24
66
WX290
NOMESCO Finland
Other blockage of nerve
1.5
7.8
391
3048
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
7.7
98
539
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
15.2
7.7
12
8
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
3.3
7.7
29
91
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.7
330
2489
M54.6
ICD-10 Finland
Pain in thoracic spine
2.2
7.7
65
308
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.6
7.7
18
40
J01CA04
ATC
amoxicillin; systemic
1.5
7.6
713
6274
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
7.6
60
276
8449X
ICD-9 Finland
Sprains and strains of knee and leg, Unspecified site of knee and leg
18.5
7.6
11
6
XQ902
NOMESCO Finland
Other photography
8.9
7.6
15
17
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.9
7.5
34
119
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.5
239
1691
R51.80
ICD-10 Finland
Headache
1.8
7.5
122
727
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
7.5
69
339
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
3.6
7.5
24
68
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.2
7.4
28
88
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.5
7.4
25
73
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
80.7
7.4
8
*
NGE15
NOMESCO Finland
Incision fo capsule of knee joint, arthroscopic
80.7
7.4
8
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
7.4
212
1463
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
7.4
102
577
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
7.3
147
928
A29
ICPC
General symptom/complaint other
1.8
7.3
114
670
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
+∞
7.3
7
*
NGF30
NOMESCO Finland
Fixation of loose body of joint of knee
+∞
7.3
7
*
7180E
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,LONKKANIVEL]
+∞
7.3
7
*
K02.1
ICD-10 Finland
Caries of dentine
1.5
7.3
490
4022
R07.0
ICD-10 Finland
Pain in throat
2.3
7.3
55
249
ZXA10
NOMESCO Finland
Bilateral
1.7
7.3
143
898
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.9
7.2
19
33
L04AB06
ATC
golimumab; parenteral
15.9
7.2
11
7
UKC02
NOMESCO Finland
Cystoscopy
1.7
7.2
132
814
L10
ICPC
Elbow symptom/complaint
2.4
7.2
48
206
NDG76
NOMESCO Finland
Fusion of DIP joint
30.3
7.2
9
*
9056A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of dislocation
30.3
7.2
9
*
R01AD12
ATC
fluticasone furoate; nasal
1.5
7.1
252
1821
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
7.1
109
637
SPAT1229
SPAT
Assessment of need for aid
2.3
7.1
53
239
B01AF02
ATC
apixaban; oral
1.8
7.1
113
669
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
7.1
106
616
K03.66
ICD-10 Finland
Tooth plaque
2.1
7.0
67
333
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
7.0
54
246
QDB10, ,
SPAT
3.2
7.0
27
86
TKC22
NOMESCO Finland
Catheterisation instruction
3.5
7.0
23
66
9242
FHL
Other reconstruction or plastic surgery of shoulder joint (including ac joint)
7.1
7.0
16
23
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
3.3
7.0
26
81
J02AC01
ATC
fluconazole; systemic
1.5
7.0
298
2236
A46
ICD-10 Finland
Erysipelas
1.8
7.0
117
702
N02AJ13
ATC
tramadol and paracetamol; systemic
3.7
6.9
21
57
L11
ICPC
Wrist symptom/complaint
2.0
6.9
71
363
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
6.9
121
736
C07AB07
ATC
bisoprolol; oral
1.4
6.9
420
3376
S15
ICPC
Foreign body in skin
2.2
6.8
54
249
M75.3
ICD-10 Finland
Calcific tendinitis of shoulder
4.2
6.8
18
44
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.8
6.8
16
24
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
6.8
55
256
R03BA02
ATC
budesonide; inhalant
1.7
6.8
145
929
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
6.8
28
93
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
6.8
460
3763
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
40.3
6.8
8
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
40.3
6.8
8
*
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
40.3
6.8
8
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
16.8
6.8
10
6
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
6.7
61
298
E0000UV, ,
ATC
1.5
6.7
331
2553
NGH20
NOMESCO Finland
Reduction of dislocation of knee joint, open
22.7
6.7
9
*
S50.0
ICD-10 Finland
Contusion of elbow
2.9
6.7
30
105
NF1AA, ,
SPAT
2.5
6.7
40
163
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.7
226
1616
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.0
6.6
75
398
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
6.6
213
1507
N06AX03
ATC
mianserin; oral
2.4
6.6
44
189
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
8.8
6.6
13
15
M43.1
ICD-10 Finland
Spondylolisthesis
2.7
6.6
33
123
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.7
6.6
33
123
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
6.6
97
561
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.9
6.6
19
50
L01
ICPC
Neck symptom/complaint
1.7
6.5
121
748
C03CA01
ATC
furosemide; systemic
1.5
6.5
224
1607
M75.2
ICD-10 Finland
Bicipital tendinitis
3.4
6.4
22
65
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.2
6.4
53
249
NBC40
NOMESCO Finland
Secondary implantation of prosthesis in humeroscapular joint, both parts
70.3
6.4
7
*
NHE20
NOMESCO Finland
Plastic repair of capsule or ligament of ankle joint with transplant
70.3
6.4
7
*
NDG30
NOMESCO Finland
Fusion of wrist, total
70.3
6.4
7
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.8
6.4
31
113
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
14.4
6.4
10
7
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.3
6.4
46
204
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.5
6.4
267
1990
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.4
209
1481
J01EA01
ATC
trimethoprim; systemic
1.5
6.4
191
1327
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
6.4
307
2352
EB1VA, ,
NOMESCO Finland
1.6
6.4
143
929
205
Kela drug reimbursment
Chronic hypertension
1.5
6.3
210
1492
R5599
NOMESCO Finland
Other rehabilitation service
3.1
6.3
25
81
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.3
378
3011
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.6
6.3
35
137
8442A
ICD-9 Finland
Sprains and strains of knee and leg, Cruciate ligament of knee[DISTORSIO/DISTEN/RUPT.LIG.CRUCIATI ANTERIORIS GENUS]
8.2
6.3
13
16
WX702
NOMESCO Finland
Supraglottic ventilation device
2.3
6.3
48
218
L04AB04
ATC
adalimumab; parenteral
6.0
6.3
16
27
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
6.3
51
238
R4110, ,
SPAT
1.8
6.3
100
591
R09
ICPC
Sinus symptom/complaint
2.1
6.3
61
306
J01XX08
ATC
linezolid; systemic
18.2
6.3
9
5
D01AC02
ATC
miconazole; topical
2.0
6.3
65
334
C10AA05
ATC
atorvastatin; oral
1.4
6.3
369
2932
L04AC07
ATC
tocilizumab; parenteral
+∞
6.3
6
*
71309
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) NUD
+∞
6.3
6
*
NGF10
NOMESCO Finland
Total synovectomy of knee, open
+∞
6.3
6
*
M24.0
ICD-10 Finland
Loose body in joint
+∞
6.3
6
*
7176A
ICD-9 Finland
Internal derangement of knee, Loose body in knee
+∞
6.3
6
*
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
+∞
6.3
6
*
349
Kela drug reimbursment
Febuxostat
+∞
6.3
6
*
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
+∞
6.3
6
*
J01DA09
ATC
[U] cefadroxil
1.5
6.3
214
1531
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
26.9
6.2
8
*
NBB10
NOMESCO Finland
Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified
26.9
6.2
8
*
M23.5
ICD-10 Finland
Chronic instability of knee
26.9
6.2
8
*
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
7.1
6.2
14
20
M25.4
ICD-10 Finland
Effusion of joint
7.1
6.2
14
20
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
6.2
92
532
R05FB02
ATC
cough suppressants and expectorants; systemic
1.4
6.2
299
2289
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
5.1
6.2
18
36
J46
ICD-10 Finland
Status asthmaticus
3.2
6.2
24
77
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
6.2
360
2853
WX204
NOMESCO Finland
Axillary plexus blockaced
2.8
6.2
30
110
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.1
304
2338
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
6.1
57
281
RF220, ,
NOMESCO Finland
7.7
6.1
13
17
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
6.1
67
351
R06AX27
ATC
desloratadine; oral
1.5
6.1
221
1598
T90
ICPC
Diabetes non-insulin dependent
1.5
6.1
212
1520
NBL05
NOMESCO Finland
Arthroscopic suture or reinsertation of rotator cuff of shoulder
3.8
6.1
18
48
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
4.2
6.1
16
39
M01AC02
ATC
tenoxicam; systemic, rectal
2.5
6.1
37
152
92700
ICD-8 Finland
Contusion of hip, thigh, leg and ankle, Current injury
8.7
6.1
12
14
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
3.6
6.1
19
53
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
10.1
6.0
11
11
L84
ICD-10 Finland
Corns and callosities
2.9
6.0
28
100
M23
ICD-10 Finland
Internal derangement of knee
3.4
6.0
21
63
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.3
6.0
46
210
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Orthopedic Surgery
20 [38004465]
20 [38004465]
1.8e+00
2.9e+00
3.8e+00
1.0e+50
3.9e+00
3.2e+00
2.2e+00
cases:12.32%
controls:2.27%
cases:12.50%
controls:0.81%
cases:6.43%
controls:0.15%
cases:33.04%
controls:0.00%
cases:4.29%
controls:0.09%
cases:18.02%
controls:0.86%
cases:22.57%
controls:3.25%
69
123
491
5302
70
44
490
5381
36
8
524
5417
185
0
375
5425
24
5
536
5418
100
46
455
5317
123
170
422
5054
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
1.3e+00
2.2e+00
2.3e+00
—
3.1e+00
2.7e+00
1.5e+00
cases:5.54%
controls:1.53%
cases:4.64%
controls:0.55%
cases:1.25%
controls:0.13%
—
—
cases:1.96%
controls:0.09%
cases:5.77%
controls:0.43%
cases:10.46%
controls:2.45%
31
83
529
5342
26
30
534
5395
7
7
553
5418
—
11
5
549
5418
32
23
523
5340
57
128
488
5096
Outpatient Visit
OP [9202]
OP [9202]
6.8e-01
9.4e-01
1.3e+00
6.7e+00
1.1e+00
1.0e+00
8.4e-01
cases:47.68%
controls:31.50%
cases:34.82%
controls:17.25%
cases:10.89%
controls:3.34%
cases:60.36%
controls:0.18%
cases:9.82%
controls:3.58%
cases:35.86%
controls:16.80%
cases:59.45%
controls:38.65%
267
1709
293
3716
195
936
365
4489
61
181
499
5244
338
10
222
5415
55
194
505
5229
199
901
356
4462
324
2019
221
3205
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
1.5e+00
2.0e+00
2.1e+00
—
2.0e+00
1.9e+00
1.7e+00
cases:7.50%
controls:1.73%
cases:5.18%
controls:0.76%
cases:1.25%
controls:0.15%
—
—
cases:1.25%
controls:0.17%
cases:5.05%
controls:0.76%
cases:12.48%
controls:2.55%
42
94
518
5331
29
41
531
5384
7
8
553
5417
—
7
9
553
5414
28
41
527
5322
68
133
477
5091
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
1.3e+00
1.4e+00
3.1e+00
—
3.0e+00
1.4e+00
9.1e-01
cases:9.64%
controls:2.84%
cases:4.82%
controls:1.24%
cases:1.96%
controls:0.09%
—
—
cases:2.50%
controls:0.13%
cases:5.23%
controls:1.34%
cases:10.83%
controls:4.67%
54
154
506
5271
27
67
533
5358
11
5
549
5420
—
14
7
546
5416
29
72
526
5291
59
244
486
4980
General Surgery
2 [38004447]
2 [38004447]
1.1e+00
1.7e+00
1.8e+00
1.0e+50
2.1e+00
1.7e+00
1.1e+00
cases:30.71%
controls:12.59%
cases:16.43%
controls:3.45%
cases:2.50%
controls:0.44%
cases:56.61%
controls:0.00%
cases:2.86%
controls:0.35%
cases:17.30%
controls:3.62%
cases:30.83%
controls:13.15%
172
683
388
4742
92
187
468
5238
14
24
546
5401
317
0
243
5425
16
19
544
5404
96
194
459
5169
168
687
377
4537
Rheumatology
66 [38004491]
66 [38004491]
2.6e+00
2.1e+00
—
—
—
2.4e+00
2.3e+00
cases:2.86%
controls:0.22%
cases:1.43%
controls:0.18%
—
—
—
—
—
—
cases:1.62%
controls:0.15%
cases:4.04%
controls:0.40%
16
12
544
5413
8
10
552
5415
—
—
—
9
8
546
5355
22
21
523
5203
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
1.1e+00
1.8e+00
2.1e+00
—
—
2.0e+00
1.6e+00
cases:2.50%
controls:0.81%
cases:2.32%
controls:0.39%
cases:1.25%
controls:0.15%
—
—
—
—
cases:2.34%
controls:0.32%
cases:5.14%
controls:1.13%
14
44
546
5381
13
21
547
5404
7
8
553
5417
—
—
13
17
542
5346
28
59
517
5165
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
2.6e+00
3.4e+00
—
1.0e+50
—
—
2.0e+00
cases:5.36%
controls:0.41%
cases:5.54%
controls:0.20%
—
—
cases:0.89%
controls:0.00%
—
—
—
—
cases:5.87%
controls:0.80%
30
22
530
5403
31
11
529
5414
—
5
0
555
5425
—
—
32
42
513
5182
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
1.7e+00
2.1e+00
—
1.0e+50
—
2.4e+00
1.7e+00
cases:2.32%
controls:0.44%
cases:1.25%
controls:0.15%
—
—
cases:2.86%
controls:0.00%
—
—
cases:1.44%
controls:0.13%
cases:4.40%
controls:0.82%
13
24
547
5401
7
8
553
5417
—
16
0
544
5425
—
8
7
547
5356
24
43
521
5181
etoricoxib; oral
M01AH05 [21603996]
M01AH05 [21603996]
1.2e+00
1.6e+00
2.1e+00
—
2.3e+00
1.2e+00
1.2e+00
cases:10.71%
controls:3.43%
cases:6.07%
controls:1.24%
cases:0.89%
controls:0.11%
—
—
cases:1.43%
controls:0.15%
cases:3.78%
controls:1.21%
cases:15.41%
controls:5.02%
60
186
500
5239
34
67
526
5358
5
6
555
5419
—
8
8
552
5415
21
65
534
5298
84
262
461
4962
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
1.5e+00
2.3e+00
—
—
1.0e+50
2.3e+00
1.3e+00
cases:2.50%
controls:0.55%
cases:1.96%
controls:0.20%
—
—
—
—
cases:0.89%
controls:0.00%
cases:2.16%
controls:0.22%
cases:3.12%
controls:0.84%
14
30
546
5395
11
11
549
5414
—
—
5
0
555
5423
12
12
543
5351
17
44
528
5180
Spinalanesthesia
WX320 [2001310799]
WX320 [2001310799]
1.7e+00
—
—
1.0e+50
—
3.2e+00
2.2e+00
cases:1.61%
controls:0.29%
—
—
—
—
cases:1.61%
controls:0.00%
—
—
cases:2.34%
controls:0.09%
cases:3.49%
controls:0.40%
9
16
551
5409
—
—
9
0
551
5425
—
13
5
542
5358
19
21
526
5203
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
1.5e+00
1.9e+00
—
—
—
1.9e+00
1.2e+00
cases:3.04%
controls:0.72%
cases:2.68%
controls:0.42%
—
—
—
—
—
—
cases:2.16%
controls:0.34%
cases:5.32%
controls:1.63%
17
39
543
5386
15
23
545
5402
—
—
—
12
18
543
5345
29
85
516
5139
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
7.5e-01
1.0e+00
1.1e+00
—
1.9e+00
9.9e-01
6.5e-01
cases:26.25%
controls:14.36%
cases:15.89%
controls:6.30%
cases:3.04%
controls:1.05%
—
—
cases:5.71%
controls:0.90%
cases:16.22%
controls:6.71%
cases:32.84%
controls:20.39%
147
779
413
4646
89
342
471
5083
17
57
543
5368
—
32
49
528
5374
90
360
465
5003
179
1065
366
4159
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
7.5e-01
1.0e+00
1.1e+00
—
1.9e+00
9.9e-01
6.5e-01
cases:26.25%
controls:14.36%
cases:15.89%
controls:6.30%
cases:3.04%
controls:1.05%
—
—
cases:5.71%
controls:0.90%
cases:16.22%
controls:6.71%
cases:32.84%
controls:20.39%
147
779
413
4646
89
342
471
5083
17
57
543
5368
—
32
49
528
5374
90
360
465
5003
179
1065
366
4159
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
9.3e-01
1.9e+00
—
1.0e+50
—
1.8e+00
1.6e+00
cases:4.29%
controls:1.73%
cases:3.57%
controls:0.55%
—
—
cases:4.64%
controls:0.00%
—
—
cases:3.78%
controls:0.62%
cases:7.89%
controls:1.72%
24
94
536
5331
20
30
540
5395
—
26
0
534
5425
—
21
33
534
5330
43
90
502
5134
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
8.9e-01
2.2e+00
—
1.0e+50
—
2.8e+00
1.3e+00
cases:1.61%
controls:0.66%
cases:1.79%
controls:0.20%
—
—
cases:1.43%
controls:0.00%
—
—
cases:2.34%
controls:0.15%
cases:2.94%
controls:0.84%
9
36
551
5389
10
11
550
5414
—
8
0
552
5425
—
13
8
542
5355
16
44
529
5180
celecoxib; oral
M01AH01 [21603992]
M01AH01 [21603992]
8.5e-01
2.6e+00
—
—
—
2.3e+00
1.3e+00
cases:1.07%
controls:0.46%
cases:1.96%
controls:0.15%
—
—
—
—
—
—
cases:1.08%
controls:0.11%
cases:2.57%
controls:0.71%
6
25
554
5400
11
8
549
5417
—
—
—
6
6
549
5357
14
37
531
5187
celecoxib
L01XX33 [21603805]
L01XX33 [21603805]
8.5e-01
2.6e+00
—
—
—
2.3e+00
1.3e+00
cases:1.07%
controls:0.46%
cases:1.96%
controls:0.15%
—
—
—
—
—
—
cases:1.08%
controls:0.11%
cases:2.57%
controls:0.71%
6
25
554
5400
11
8
549
5417
—
—
—
6
6
549
5357
14
37
531
5187
glucosamine; oral
M01AX05 [21604002]
M01AX05 [21604002]
1.6e+00
2.0e+00
—
—
1.0e+50
2.7e+00
2.0e+00
cases:3.04%
controls:0.65%
cases:1.07%
controls:0.15%
—
—
—
—
cases:1.61%
controls:0.00%
cases:2.34%
controls:0.17%
cases:4.40%
controls:0.65%
17
35
543
5390
6
8
554
5417
—
—
9
0
551
5423
13
9
542
5354
24
34
521
5190
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
9.0e-01
1.6e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:3.39%
controls:1.40%
cases:2.50%
controls:0.50%
—
—
cases:3.39%
controls:0.00%
—
—
cases:3.24%
controls:0.35%
cases:4.77%
controls:1.30%
19
76
541
5349
14
27
546
5398
—
19
0
541
5425
—
18
19
537
5344
26
68
519
5156
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
1.1e+00
1.7e+00
—
1.0e+50
—
2.7e+00
1.7e+00
cases:2.14%
controls:0.72%
cases:1.61%
controls:0.29%
—
—
cases:3.04%
controls:0.00%
—
—
cases:2.52%
controls:0.17%
cases:4.40%
controls:0.86%
12
39
548
5386
9
16
551
5409
—
17
0
543
5425
—
14
9
541
5354
24
45
521
5179
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
9.7e-01
2.2e+00
—
1.0e+50
—
2.2e+00
1.4e+00
cases:1.96%
controls:0.76%
cases:1.43%
controls:0.17%
—
—
cases:1.25%
controls:0.00%
—
—
cases:2.70%
controls:0.30%
cases:4.22%
controls:1.05%
11
41
549
5384
8
9
552
5416
—
7
0
553
5425
—
15
16
540
5347
23
55
522
5169
nimesulide; oral
M01AX17 [21604007]
M01AX17 [21604007]
1.1e+00
1.9e+00
—
—
—
1.7e+00
1.1e+00
cases:2.50%
controls:0.87%
cases:2.14%
controls:0.31%
—
—
—
—
—
—
cases:1.44%
controls:0.26%
cases:3.49%
controls:1.24%
14
47
546
5378
12
17
548
5408
—
—
—
8
14
547
5349
19
65
526
5159
Hand Surgery
40 [38004480]
40 [38004480]
1.1e+00
2.1e+00
—
—
—
2.1e+00
1.5e+00
cases:1.79%
controls:0.63%
cases:1.61%
controls:0.20%
—
—
—
—
—
—
cases:2.16%
controls:0.26%
cases:4.04%
controls:0.92%
10
34
550
5391
9
11
551
5414
—
—
—
12
14
543
5349
22
48
523
5176
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
M01AE03 [21603969]
8.8e-01
8.0e-01
—
—
2.9e+00
1.2e+00
7.6e-01
cases:7.86%
controls:3.43%
cases:3.39%
controls:1.55%
—
—
—
—
cases:1.96%
controls:0.11%
cases:3.96%
controls:1.25%
cases:9.54%
controls:4.71%
44
186
516
5239
19
84
541
5341
—
—
11
6
549
5417
22
67
533
5296
52
246
493
4978
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
1.2e+00
1.4e+00
—
—
—
1.3e+00
1.2e+00
cases:3.21%
controls:1.03%
cases:2.14%
controls:0.52%
—
—
—
—
—
—
cases:2.52%
controls:0.73%
cases:5.87%
controls:1.91%
18
56
542
5369
12
28
548
5397
—
—
—
14
39
541
5324
32
100
513
5124
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
6.8e-01
8.4e-01
1.1e+00
1.0e+50
1.7e+00
1.0e+00
7.3e-01
cases:13.75%
controls:7.48%
cases:8.21%
controls:3.71%
cases:1.43%
controls:0.46%
cases:2.14%
controls:0.00%
cases:2.14%
controls:0.41%
cases:9.73%
controls:3.67%
cases:22.20%
controls:12.06%
77
406
483
5019
46
201
514
5224
8
25
552
5400
12
0
548
5425
12
22
548
5401
54
197
501
5166
121
630
424
4594
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
1.4e-01
4.3e-01
5.3e-01
2.7e+00
8.5e-01
4.2e-01
2.2e-01
cases:56.96%
controls:53.46%
cases:56.61%
controls:45.92%
cases:25.89%
controls:17.01%
cases:10.36%
controls:0.74%
cases:30.71%
controls:15.90%
cases:59.64%
controls:49.38%
cases:77.43%
controls:73.43%
319
2900
241
2525
317
2491
243
2934
145
923
415
4502
58
40
502
5385
172
862
388
4561
331
2648
224
2715
422
3836
123
1388
Rotator cuff syndrome
M75.1 [45596678]
M75.1 [45596678]
1.0e+00
1.8e+00
—
—
—
1.9e+00
1.2e+00
cases:1.25%
controls:0.44%
cases:1.43%
controls:0.24%
—
—
—
—
—
—
cases:1.62%
controls:0.24%
cases:4.40%
controls:1.32%
7
24
553
5401
8
13
552
5412
—
—
—
9
13
546
5350
24
69
521
5155
Internal derangement of knee, unspecified
M23.9 [45567507]
M23.9 [45567507]
2.4e+00
—
—
—
—
—
2.5e+00
cases:1.43%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.13%
8
7
552
5418
—
—
—
—
—
9
7
536
5217
Outpatient Hospital
22 [8756]
22 [8756]
5.9e-01
6.8e-01
1.5e+00
—
1.2e+00
1.3e+00
8.2e-01
cases:15.36%
controls:9.16%
cases:6.79%
controls:3.56%
cases:1.79%
controls:0.39%
—
—
cases:1.25%
controls:0.39%
cases:11.53%
controls:3.51%
cases:25.14%
controls:12.90%
86
497
474
4928
38
193
522
5232
10
21
550
5404
—
7
21
553
5402
64
188
491
5175
137
674
408
4550
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
M01AC01 [21603961]
8.1e-01
1.6e+00
—
—
—
1.3e+00
1.0e+00
cases:5.71%
controls:2.64%
cases:3.93%
controls:0.83%
—
—
—
—
—
—
cases:3.42%
controls:0.93%
cases:10.64%
controls:4.08%
32
143
528
5282
22
45
538
5380
—
—
—
19
50
536
5313
58
213
487
5011
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
8.0e-01
1.5e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:3.75%
controls:1.71%
cases:2.68%
controls:0.63%
—
—
cases:3.39%
controls:0.00%
—
—
cases:3.42%
controls:0.52%
cases:6.06%
controls:1.65%
21
93
539
5332
15
34
545
5391
—
19
0
541
5425
—
19
28
536
5335
33
86
512
5138
piroxicam; ointment
M02AA07 [21604043]
M02AA07 [21604043]
8.9e-01
1.5e+00
—
—
—
1.3e+00
9.9e-01
cases:5.00%
controls:2.12%
cases:3.21%
controls:0.76%
—
—
—
—
—
—
cases:2.52%
controls:0.71%
cases:8.44%
controls:3.31%
28
115
532
5310
18
41
542
5384
—
—
—
14
38
541
5325
46
173
499
5051
Tear of meniscus, current
S83.2 [45555441]
S83.2 [45555441]
2.5e+00
—
—
—
—
—
2.0e+00
cases:1.07%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.23%
6
5
554
5420
—
—
—
—
—
9
12
536
5212
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
1.4e+00
—
1.0e+50
—
1.0e+50
2.6e+00
1.7e+00
cases:1.43%
controls:0.37%
—
—
cases:1.07%
controls:0.00%
—
—
cases:0.89%
controls:0.00%
cases:1.80%
controls:0.13%
cases:3.12%
controls:0.61%
8
20
552
5405
—
6
0
554
5425
—
5
0
555
5423
10
7
545
5356
17
32
528
5192
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
M01AC06 [21603965]
8.7e-01
2.1e+00
—
—
—
1.2e+00
1.3e+00
cases:4.29%
controls:1.84%
cases:2.86%
controls:0.37%
—
—
—
—
—
—
cases:1.80%
controls:0.56%
cases:8.26%
controls:2.30%
24
100
536
5325
16
20
544
5405
—
—
—
10
30
545
5333
45
120
500
5104
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.4e-01
2.2e-01
5.6e-01
2.8e+00
5.4e-01
1.4e-01
1.2e-01
cases:22.86%
controls:20.46%
cases:19.11%
controls:15.87%
cases:9.29%
controls:5.51%
cases:5.54%
controls:0.35%
cases:8.93%
controls:5.42%
cases:19.46%
controls:17.38%
cases:34.86%
controls:32.10%
128
1110
432
4315
107
861
453
4564
52
299
508
5126
31
19
529
5406
50
294
510
5129
108
932
447
4431
190
1677
355
3547
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.8e-01
6.2e-01
4.5e-01
—
1.6e+00
7.0e-01
4.2e-01
cases:19.82%
controls:13.27%
cases:8.21%
controls:4.59%
cases:0.89%
controls:0.57%
—
—
cases:1.79%
controls:0.37%
cases:8.65%
controls:4.49%
cases:25.14%
controls:18.05%
111
720
449
4705
46
249
514
5176
5
31
555
5394
—
10
20
550
5403
48
241
507
5122
137
943
408
4281
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
8.4e-01
1.0e+00
1.7e+00
—
1.6e+00
1.1e+00
8.0e-01
cases:14.82%
controls:6.97%
cases:6.61%
controls:2.51%
cases:1.25%
controls:0.22%
—
—
cases:1.25%
controls:0.26%
cases:6.67%
controls:2.35%
cases:18.90%
controls:9.51%
83
378
477
5047
37
136
523
5289
7
12
553
5413
—
7
14
553
5409
37
126
518
5237
103
497
442
4727
Inpatient Visit
IP [9201]
IP [9201]
6.2e-01
1.1e+00
—
—
—
1.1e+00
8.0e-01
cases:25.00%
controls:15.19%
cases:8.75%
controls:3.17%
—
—
—
—
—
—
cases:9.37%
controls:3.24%
cases:15.23%
controls:7.47%
140
824
420
4601
49
172
511
5253
—
—
—
52
174
503
5189
83
390
462
4834
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
1.4e+00
—
—
—
—
2.0e+00
1.5e+00
cases:1.61%
controls:0.39%
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.17%
cases:3.12%
controls:0.73%
9
21
551
5404
—
—
—
—
7
9
548
5354
17
38
528
5186
Emergency Room Visit
ER [9203]
ER [9203]
5.9e-01
5.3e-01
6.4e-01
—
1.6e+00
6.1e-01
5.9e-01
cases:19.82%
controls:12.06%
cases:7.14%
controls:4.33%
cases:1.25%
controls:0.66%
—
—
cases:1.96%
controls:0.41%
cases:8.29%
controls:4.66%
cases:24.59%
controls:15.31%
111
654
449
4771
40
235
520
5190
7
36
553
5389
—
11
22
549
5401
46
250
509
5113
134
800
411
4424
methotrexate
L01BA01 [21601423]
L01BA01 [21601423]
—
—
—
—
—
—
3.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.10%
—
—
—
—
—
—
15
5
530
5219
methotrexate; oral, parenteral
L04AX03 [21603929]
L04AX03 [21603929]
—
—
—
—
—
—
3.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.10%
—
—
—
—
—
—
15
5
530
5219
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
8.4e-01
1.5e+00
—
—
—
1.9e+00
1.4e+00
cases:1.61%
controls:0.70%
cases:1.25%
controls:0.29%
—
—
—
—
—
—
cases:1.44%
controls:0.22%
cases:3.67%
controls:0.94%
9
38
551
5387
7
16
553
5409
—
—
—
8
12
547
5351
20
49
525
5175
naproxen and esomeprazole; oral
M01AE52 [40254096]
M01AE52 [40254096]
1.8e+00
—
—
—
—
—
1.4e+00
cases:1.61%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.50%
9
14
551
5411
—
—
—
—
—
11
26
534
5198
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
2.1e-01
1.9e+00
—
—
—
—
1.3e+00
cases:1.25%
controls:1.01%
cases:1.25%
controls:0.18%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.65%
7
55
553
5370
7
10
553
5415
—
—
—
—
13
34
532
5190
Knee X-ray examination without contrast
NG1AA [2001308049]
NG1AA [2001308049]
—
—
—
—
—
—
3.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.11%
—
—
—
—
—
—
15
6
530
5218
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
1.4e+00
1.7e+00
2.1e+00
—
—
1.2e+00
8.0e-01
cases:2.50%
controls:0.63%
cases:1.79%
controls:0.33%
cases:0.89%
controls:0.11%
—
—
—
—
cases:1.08%
controls:0.32%
cases:3.30%
controls:1.51%
14
34
546
5391
10
18
550
5407
5
6
555
5419
—
—
6
17
549
5346
18
79
527
5145
Partial excision of meniscus of knee, arthroscopic
NGD05 [2001308109]
NGD05 [2001308109]
—
—
—
1.0e+50
—
—
3.0e+00
—
—
—
—
—
—
cases:3.21%
controls:0.00%
—
—
—
—
cases:3.12%
controls:0.15%
—
—
—
18
0
542
5425
—
—
17
8
528
5216
Foot/toe symptom/complaint
L17 [2002000641]
L17 [2002000641]
1.2e+00
—
—
—
—
1.8e+00
1.2e+00
cases:1.96%
controls:0.61%
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.21%
cases:2.39%
controls:0.75%
11
33
549
5392
—
—
—
—
7
11
548
5352
13
39
532
5185
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
1.4e+00
—
—
—
—
—
1.4e+00
cases:2.32%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
cases:3.30%
controls:0.80%
13
31
547
5394
—
—
—
—
—
18
42
527
5182
Pulmonary Disease
29 [38004472]
29 [38004472]
9.4e-01
1.0e+00
—
—
1.9e+00
5.9e-01
8.9e-01
cases:5.54%
controls:2.25%
cases:3.04%
controls:1.11%
—
—
—
—
cases:0.89%
controls:0.13%
cases:2.16%
controls:1.21%
cases:8.44%
controls:3.66%
31
122
529
5303
17
60
543
5365
—
—
5
7
555
5416
12
65
543
5298
46
191
499
5033
hydrochlorothiazide and potassium-sparing agents
C03EA01 [21601543]
C03EA01 [21601543]
1.3e+00
1.5e+00
—
—
—
1.1e+00
6.9e-01
cases:2.50%
controls:0.70%
cases:1.96%
controls:0.42%
—
—
—
—
—
—
cases:1.62%
controls:0.52%
cases:2.75%
controls:1.40%
14
38
546
5387
11
23
549
5402
—
—
—
9
28
546
5335
15
73
530
5151
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
7.7e-01
4.5e-01
—
—
—
1.1e+00
8.8e-01
cases:5.36%
controls:2.54%
cases:1.79%
controls:1.14%
—
—
—
—
—
—
cases:2.70%
controls:0.88%
cases:7.71%
controls:3.35%
30
138
530
5287
10
62
550
5363
—
—
—
15
47
540
5316
42
175
503
5049
Knee symptom/complaint
L15 [2002000639]
L15 [2002000639]
1.0e+00
2.8e+00
—
—
—
—
1.2e+00
cases:0.89%
controls:0.33%
cases:1.43%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.56%
5
18
555
5407
8
5
552
5420
—
—
—
—
10
29
535
5195
levocetirizine; oral
R06AE09 [21603498]
R06AE09 [21603498]
3.8e-01
—
—
—
—
1.6e+00
1.2e+00
cases:1.43%
controls:0.98%
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.34%
cases:2.94%
controls:0.94%
8
53
552
5372
—
—
—
—
9
18
546
5345
16
49
529
5175
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
2.7e-01
4.4e-01
5.9e-01
—
1.9e+00
7.7e-01
9.9e-02
cases:6.96%
controls:5.40%
cases:3.75%
controls:2.45%
cases:0.89%
controls:0.50%
—
—
cases:1.79%
controls:0.26%
cases:5.59%
controls:2.67%
cases:8.99%
controls:8.21%
39
293
521
5132
21
133
539
5292
5
27
555
5398
—
10
14
550
5409
31
143
524
5220
49
429
496
4795
Otolaryngology
4 [38004449]
4 [38004449]
7.5e-01
1.2e+00
—
—
—
6.0e-01
7.5e-01
cases:9.82%
controls:4.90%
cases:4.64%
controls:1.47%
—
—
—
—
—
—
cases:3.42%
controls:1.90%
cases:11.19%
controls:5.63%
55
266
505
5159
26
80
534
5345
—
—
—
19
102
536
5261
61
294
484
4930
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
N04AB02 [21604458]
7.9e-01
1.1e+00
—
—
-1.0e+50
1.0e+00
7.2e-01
cases:5.54%
controls:2.58%
cases:2.50%
controls:0.88%
—
—
—
—
cases:0.00%
controls:0.13%
cases:2.52%
controls:0.93%
cases:7.16%
controls:3.60%
31
140
529
5285
14
48
546
5377
—
—
0
7
560
5416
14
50
541
5313
39
188
506
5036
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
M03BC01 [21604112]
7.9e-01
1.1e+00
—
—
-1.0e+50
1.0e+00
7.2e-01
cases:5.54%
controls:2.58%
cases:2.50%
controls:0.88%
—
—
—
—
cases:0.00%
controls:0.13%
cases:2.52%
controls:0.93%
cases:7.16%
controls:3.60%
31
140
529
5285
14
48
546
5377
—
—
0
7
560
5416
14
50
541
5313
39
188
506
5036
naproxcinod
M01AE18 [40254094]
M01AE18 [40254094]
8.7e-01
1.0e+00
—
—
—
3.9e-01
6.4e-01
cases:11.43%
controls:5.11%
cases:6.07%
controls:2.25%
—
—
—
—
—
—
cases:3.42%
controls:2.35%
cases:14.31%
controls:8.08%
64
277
496
5148
34
122
526
5303
—
—
—
19
126
536
5237
78
422
467
4802
naproxen; oral, rectal
M01AE02 [21603968]
M01AE02 [21603968]
8.7e-01
1.0e+00
—
—
—
3.9e-01
6.4e-01
cases:11.43%
controls:5.11%
cases:6.07%
controls:2.25%
—
—
—
—
—
—
cases:3.42%
controls:2.35%
cases:14.31%
controls:8.08%
64
277
496
5148
34
122
526
5303
—
—
—
19
126
536
5237
78
422
467
4802
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
2.5e+00
—
—
—
—
—
—
cases:1.07%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
554
5420
—
—
—
—
—
—
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
2.5e+00
—
—
—
—
—
—
cases:1.07%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
554
5420
—
—
—
—
—
—
azithromycin; oral, parenteral
J01FA10 [21602978]
J01FA10 [21602978]
5.7e-01
1.2e+00
—
—
—
4.8e-01
7.2e-01
cases:10.00%
controls:5.90%
cases:5.18%
controls:1.70%
—
—
—
—
—
—
cases:3.60%
controls:2.26%
cases:14.31%
controls:7.54%
56
320
504
5105
29
92
531
5333
—
—
—
20
121
535
5242
78
394
467
4830
Lateral epicondylitis
M77.1 [45572551]
M77.1 [45572551]
2.4e+00
—
—
—
—
—
9.2e-01
cases:1.25%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.52%
7
6
553
5419
—
—
—
—
—
7
27
538
5197
Arthroscopy
1220 [2000100102]
1220 [2000100102]
2.4e+00
—
—
1.0e+50
—
—
—
cases:1.25%
controls:0.11%
—
—
—
—
cases:11.25%
controls:0.00%
—
—
—
—
—
—
7
6
553
5419
—
—
63
0
497
5425
—
—
—
Deviated nasal septum
J34.2 [45562448]
J34.2 [45562448]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.11%
—
—
—
—
—
—
7
6
538
5218
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.15%
—
—
—
—
—
—
9
8
536
5216
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
1.5e+00
—
—
—
—
—
2.4e+00
cases:0.89%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.15%
5
11
555
5414
—
—
—
—
—
9
8
536
5216
Foot and toes X-ray examination
NH3AA [2001308267]
NH3AA [2001308267]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.15%
—
—
—
—
—
—
9
8
536
5216
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
1.4e+00
—
—
—
—
—
9.9e-01
cases:1.96%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
cases:2.94%
controls:1.11%
11
27
549
5398
—
—
—
—
—
16
58
529
5166
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
1.7e+00
—
—
—
—
—
2.4e+00
cases:1.25%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.19%
7
13
553
5412
—
—
—
—
—
11
10
534
5214
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
N02BE51 [21604348]
6.7e-01
9.2e-01
-1.0e+50
—
-1.0e+50
1.4e+00
8.9e-01
cases:3.21%
controls:1.68%
cases:1.61%
controls:0.65%
cases:0.00%
controls:0.09%
—
—
cases:0.00%
controls:0.09%
cases:2.34%
controls:0.58%
cases:4.95%
controls:2.11%
18
91
542
5334
9
35
551
5390
0
5
560
5420
—
0
5
560
5418
13
31
542
5332
27
110
518
5114
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
7.6e-01
5.9e-01
—
—
8.9e-01
8.1e-01
7.2e-01
cases:12.32%
controls:6.14%
cases:4.29%
controls:2.41%
—
—
—
—
cases:0.89%
controls:0.37%
cases:5.95%
controls:2.74%
cases:15.96%
controls:8.44%
69
333
491
5092
24
131
536
5294
—
—
5
20
555
5403
33
147
522
5216
87
441
458
4783
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.23%
—
—
—
—
—
—
12
12
533
5212
orphenadrine, combinations
M03BC51 [21604113]
M03BC51 [21604113]
6.6e-01
8.2e-01
—
—
—
1.4e+00
8.9e-01
cases:2.86%
controls:1.49%
cases:1.25%
controls:0.55%
—
—
—
—
—
—
cases:1.98%
controls:0.50%
cases:4.40%
controls:1.86%
16
81
544
5344
7
30
553
5395
—
—
—
11
27
544
5336
24
97
521
5127
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
NA3BG [2001307034]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.17%
—
—
—
—
—
—
9
9
536
5215
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
—
—
—
—
—
—
6
6
539
5218
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
—
—
—
—
—
—
6
6
539
5218
Other spondylosis with radiculopathy
M47.2 [45591850]
M47.2 [45591850]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
—
—
—
—
—
—
6
6
539
5218
FEV1
20150-9 [3024653]
20150-9 [3024653]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.11%
—
—
—
—
—
—
6
6
539
5218
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
8.1e-01
4.7e-01
8.1e-01
—
—
8.3e-01
6.3e-01
cases:20.36%
controls:10.25%
cases:6.61%
controls:4.24%
cases:1.07%
controls:0.48%
—
—
—
—
cases:9.55%
controls:4.40%
cases:25.32%
controls:15.26%
114
556
446
4869
37
230
523
5195
6
26
554
5399
—
—
53
236
502
5127
138
797
407
4427
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
7.4e-01
1.3e+00
—
—
—
9.4e-01
9.3e-01
cases:3.21%
controls:1.57%
cases:2.86%
controls:0.77%
—
—
—
—
—
—
cases:1.80%
controls:0.71%
cases:5.14%
controls:2.09%
18
85
542
5340
16
42
544
5383
—
—
—
10
38
545
5325
28
109
517
5115
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.25%
—
—
—
—
—
—
12
13
533
5211
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
6.9e-01
9.7e-01
—
—
—
1.2e+00
9.6e-01
cases:1.96%
controls:1.00%
cases:1.96%
controls:0.76%
—
—
—
—
—
—
cases:2.70%
controls:0.80%
cases:4.77%
controls:1.88%
11
54
549
5371
11
41
549
5384
—
—
—
15
43
540
5320
26
98
519
5126
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
4.2e-01
1.2e+00
—
—
—
5.8e-01
1.0e+00
cases:5.89%
controls:3.94%
cases:4.46%
controls:1.42%
—
—
—
—
—
—
cases:2.34%
controls:1.32%
cases:11.38%
controls:4.44%
33
214
527
5211
25
77
535
5348
—
—
—
13
71
542
5292
62
232
483
4992
Malaise and fatigue
R53 [45553741]
R53 [45553741]
1.0e+00
1.7e+00
—
—
—
2.2e+00
3.9e-01
cases:1.43%
controls:0.52%
cases:0.89%
controls:0.17%
—
—
—
—
—
—
cases:1.44%
controls:0.17%
cases:1.65%
controls:1.13%
8
28
552
5397
5
9
555
5416
—
—
—
8
9
547
5354
9
59
536
5165
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
NA1BG [2001306990]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.15%
—
—
—
—
—
—
7
8
538
5216
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
NA3AA [2001307026]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.15%
—
—
—
—
—
—
7
8
538
5216
Shoulder X-ray examination without contrast
NB1AA [2001307225]
NB1AA [2001307225]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.15%
—
—
—
—
—
—
7
8
538
5216
hydroxychloroquine; oral
P01BA02 [21604889]
P01BA02 [21604889]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.13%
—
—
—
—
—
—
6
7
539
5217
carisoprodol; oral
M03BA02 [21604094]
M03BA02 [21604094]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.13%
—
—
—
—
—
—
6
7
539
5217
rivaroxaban; oral
B01AF01 [43534761]
B01AF01 [43534761]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.25%
—
—
—
—
—
—
11
13
534
5211
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.21%
—
—
—
—
—
—
9
11
536
5213
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
1.1e+00
—
—
—
—
1.4e+00
9.2e-01
cases:2.32%
controls:0.77%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.28%
cases:3.85%
controls:1.57%
13
42
547
5383
—
—
—
—
6
15
549
5348
21
82
524
5142
brompheniramine, combinations
R06AB51 [21603466]
R06AB51 [21603466]
9.6e-01
5.2e-01
—
—
—
5.7e-01
1.0e+00
cases:3.75%
controls:1.47%
cases:0.89%
controls:0.53%
—
—
—
—
—
—
cases:1.08%
controls:0.62%
cases:6.24%
controls:2.34%
21
80
539
5345
5
29
555
5396
—
—
—
6
33
549
5330
34
122
511
5102
phenylephrine, combinations
R01BA53 [21603214]
R01BA53 [21603214]
9.4e-01
5.2e-01
—
—
—
5.7e-01
1.0e+00
cases:3.75%
controls:1.49%
cases:0.89%
controls:0.53%
—
—
—
—
—
—
cases:1.08%
controls:0.62%
cases:6.24%
controls:2.34%
21
81
539
5344
5
29
555
5396
—
—
—
6
33
549
5330
34
122
511
5102
chlorphenamine, combinations
R06AB54 [21603468]
R06AB54 [21603468]
9.4e-01
5.2e-01
—
—
—
5.7e-01
1.0e+00
cases:3.75%
controls:1.49%
cases:0.89%
controls:0.53%
—
—
—
—
—
—
cases:1.08%
controls:0.62%
cases:6.24%
controls:2.34%
21
81
539
5344
5
29
555
5396
—
—
—
6
33
549
5330
34
122
511
5102
dextropropoxyphene; oral
N02AC04 [21604278]
N02AC04 [21604278]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.21%
—
—
—
—
—
—
8
11
537
5213
Ankle X-ray examination without contrast
NH1AA [2001308235]
NH1AA [2001308235]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.21%
—
—
—
—
—
—
8
11
537
5213
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
8.7e-01
1.1e-01
—
—
—
7.9e-01
1.1e+00
cases:5.00%
controls:2.16%
cases:1.07%
controls:0.96%
—
—
—
—
—
—
cases:2.16%
controls:0.99%
cases:9.36%
controls:3.45%
28
117
532
5308
6
52
554
5373
—
—
—
12
53
543
5310
51
180
494
5044
dextromethorphan; oral
R05DA09 [21603404]
R05DA09 [21603404]
9.4e-01
—
—
—
—
4.1e-01
9.8e-01
cases:3.57%
controls:1.42%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.60%
cases:5.32%
controls:2.07%
20
77
540
5348
—
—
—
—
5
32
550
5331
29
108
516
5116
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
9.9e-01
2.4e-01
—
—
-1.0e+50
4.8e-01
9.3e-01
cases:4.11%
controls:1.57%
cases:1.07%
controls:0.85%
—
—
—
—
cases:0.00%
controls:0.20%
cases:1.26%
controls:0.78%
cases:6.06%
controls:2.49%
23
85
537
5340
6
46
554
5379
—
—
0
11
560
5412
7
42
548
5321
33
130
512
5094
pramipexole; oral
N04BC05 [21604477]
N04BC05 [21604477]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.19%
—
—
—
—
—
—
7
10
538
5214
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
Y83 [45552036]
1.2e+00
—
—
—
—
—
1.9e+00
cases:0.89%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.19%
5
14
555
5411
—
—
—
—
—
7
10
538
5214
salbutamol; oral, parenteral
R03CC02 [21603312]
R03CC02 [21603312]
9.2e-01
—
—
—
—
6.3e-01
9.8e-01
cases:3.57%
controls:1.46%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.58%
cases:5.32%
controls:2.07%
20
79
540
5346
—
—
—
—
6
31
549
5332
29
108
516
5116
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
8.3e-01
1.1e-01
—
—
—
7.9e-01
1.1e+00
cases:4.82%
controls:2.16%
cases:1.07%
controls:0.96%
—
—
—
—
—
—
cases:2.16%
controls:0.99%
cases:9.36%
controls:3.45%
27
117
533
5308
6
52
554
5373
—
—
—
12
53
543
5310
51
180
494
5044
intermediate-acting sulfonamides - combinations
J01EC20 [21602948]
J01EC20 [21602948]
9.3e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.36%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
74
541
5351
—
—
—
—
5
31
550
5332
28
106
517
5118
diphenhydramine, combinations
R06AA52 [21603454]
R06AA52 [21603454]
9.3e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.36%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
74
541
5351
—
—
—
—
5
31
550
5332
28
106
517
5118
long-acting sulfonamides - combinations
J01ED20 [21602959]
J01ED20 [21602959]
9.3e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.36%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
74
541
5351
—
—
—
—
5
31
550
5332
28
106
517
5118
short-acting sulfonamides - combinations
J01EB20 [21602943]
J01EB20 [21602943]
9.3e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.36%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
74
541
5351
—
—
—
—
5
31
550
5332
28
106
517
5118
cough suppressants and mucolytics
R05FB01 [21603441]
R05FB01 [21603441]
9.3e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.36%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
74
541
5351
—
—
—
—
5
31
550
5332
28
106
517
5118
hydroxyethylpromethazine, combinations
R06AD55 [21603490]
R06AD55 [21603490]
9.2e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.38%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
75
541
5350
—
—
—
—
5
31
550
5332
28
106
517
5118
promethazine, combinations
R06AD52 [21603489]
R06AD52 [21603489]
9.2e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.38%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
75
541
5350
—
—
—
—
5
31
550
5332
28
106
517
5118
dextromethorphan, combinations; oral
N07XX59 [43534835]
N07XX59 [43534835]
9.2e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.38%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
75
541
5350
—
—
—
—
5
31
550
5332
28
106
517
5118
cough suppressants and expectorants
R05FB02 [21603442]
R05FB02 [21603442]
9.2e-01
—
—
—
—
4.5e-01
9.6e-01
cases:3.39%
controls:1.38%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.58%
cases:5.14%
controls:2.03%
19
75
541
5350
—
—
—
—
5
31
550
5332
28
106
517
5118
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.29%
—
—
—
—
—
—
10
15
535
5209
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.38%
—
—
—
—
—
—
13
20
532
5204
budesonide; inhalant
R03BA02 [21603285]
R03BA02 [21603285]
9.6e-01
6.1e-01
1.4e+00
—
—
8.4e-01
8.8e-01
cases:5.18%
controls:2.05%
cases:2.32%
controls:1.27%
cases:0.89%
controls:0.22%
—
—
—
—
cases:3.06%
controls:1.34%
cases:6.42%
controls:2.76%
29
111
531
5314
13
69
547
5356
5
12
555
5413
—
—
17
72
538
5291
35
144
510
5080
Moderate depressive episode
F32.1 [45552478]
F32.1 [45552478]
1.8e+00
—
—
—
—
—
1.7e+00
cases:1.25%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.25%
7
11
553
5414
—
—
—
—
—
7
13
538
5211
Hand and fingers X-ray examination
ND2AA [2001307607]
ND2AA [2001307607]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.21%
—
—
—
—
—
—
7
11
538
5213
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.31%
—
—
—
—
—
—
10
16
535
5208
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
6.0e-01
9.0e-01
1.2e+00
—
—
4.4e-01
9.0e-01
cases:6.43%
controls:3.65%
cases:4.46%
controls:1.86%
cases:1.07%
controls:0.33%
—
—
—
—
cases:3.24%
controls:2.11%
cases:13.94%
controls:6.18%
36
198
524
5227
25
101
535
5324
6
18
554
5407
—
—
18
113
537
5250
76
323
469
4901
opium derivatives and expectorants
R05FA02 [21603439]
R05FA02 [21603439]
8.8e-01
—
—
—
—
4.1e-01
9.1e-01
cases:3.39%
controls:1.44%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.60%
cases:5.32%
controls:2.22%
19
78
541
5347
—
—
—
—
5
32
550
5331
29
116
516
5108
phenylpropanolamine, combinations; oral
R01BA51 [21603212]
R01BA51 [21603212]
8.8e-01
—
—
—
—
4.1e-01
9.1e-01
cases:3.39%
controls:1.44%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.60%
cases:5.32%
controls:2.22%
19
78
541
5347
—
—
—
—
5
32
550
5331
29
116
516
5108
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.38%
—
—
—
—
—
—
12
20
533
5204
budesonide; nasal
R01AD05 [21605047]
R01AD05 [21605047]
1.7e+00
—
—
—
—
—
—
cases:1.43%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
8
14
552
5411
—
—
—
—
—
—
roxithromycin; oral
J01FA06 [21602974]
J01FA06 [21602974]
8.6e-01
5.5e-01
—
—
—
6.2e-01
8.6e-01
cases:6.79%
controls:2.99%
cases:1.43%
controls:0.83%
—
—
—
—
—
—
cases:1.62%
controls:0.88%
cases:8.81%
controls:3.94%
38
162
522
5263
8
45
552
5380
—
—
—
9
47
546
5316
48
206
497
5018
Ultrasound measurement of residual urine
KC1EE [2001305918]
KC1EE [2001305918]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.27%
—
—
—
—
—
—
8
14
537
5210
tadalafil; oral
G04BE08 [21602653]
G04BE08 [21602653]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.27%
—
—
—
—
—
—
8
14
537
5210
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
9.9e-01
1.5e+00
—
—
—
1.3e+00
1.7e+00
cases:2.14%
controls:0.81%
cases:1.43%
controls:0.33%
—
—
—
—
—
—
cases:0.90%
controls:0.24%
cases:4.22%
controls:0.80%
12
44
548
5381
8
18
552
5407
—
—
—
5
13
550
5350
23
42
522
5182
rofecoxib; oral
M01AH02 [21603993]
M01AH02 [21603993]
1.1e+00
—
—
—
—
—
1.6e+00
cases:1.07%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.29%
6
19
554
5406
—
—
—
—
—
8
15
537
5209
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
7.9e-01
8.0e-01
-1.0e+50
1.0e+50
—
3.8e-01
8.2e-01
cases:5.18%
controls:2.41%
cases:1.79%
controls:0.81%
cases:0.00%
controls:0.29%
cases:1.07%
controls:0.00%
—
—
cases:1.44%
controls:0.99%
cases:7.16%
controls:3.27%
29
131
531
5294
10
44
550
5381
0
16
560
5409
6
0
554
5425
—
8
53
547
5310
39
171
506
5053
Inpatient Hospital
21 [8717]
21 [8717]
2.4e-01
3.9e-01
1.0e+00
—
1.2e+00
8.6e-01
7.4e-01
cases:20.54%
controls:16.85%
cases:8.21%
controls:5.71%
cases:1.61%
controls:0.59%
—
—
cases:1.79%
controls:0.57%
cases:13.15%
controls:6.00%
cases:33.39%
controls:19.30%
115
914
445
4511
46
310
514
5115
9
32
551
5393
—
10
31
550
5392
73
322
482
5041
182
1008
363
4216
General Practice
1 [38004446]
1 [38004446]
3.6e-01
8.1e-01
—
—
—
9.4e-01
6.6e-01
cases:4.46%
controls:3.17%
cases:2.32%
controls:1.05%
—
—
—
—
—
—
cases:3.24%
controls:1.29%
cases:8.81%
controls:4.77%
25
172
535
5253
13
57
547
5368
—
—
—
18
69
537
5294
48
249
497
4975
aciclovir; oral, parenteral
J05AB01 [21603131]
J05AB01 [21603131]
7.4e-01
1.2e+00
—
—
—
1.6e+00
8.6e-01
cases:2.32%
controls:1.12%
cases:1.25%
controls:0.39%
—
—
—
—
—
—
cases:1.62%
controls:0.34%
cases:3.49%
controls:1.51%
13
61
547
5364
7
21
553
5404
—
—
—
9
18
546
5345
19
79
526
5145
Spinal stenosis
M48.0 [45557888]
M48.0 [45557888]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.34%
—
—
—
—
—
—
9
18
536
5206
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
G03BA03 [21602510]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.44%
—
—
—
—
—
—
11
23
534
5201
Other specified intervertebral disc degeneration
M51.3 [45591865]
M51.3 [45591865]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.36%
—
—
—
—
—
—
9
19
536
5205
indometacin; oral, parenteral, rectal
M01AB01 [21603941]
M01AB01 [21603941]
9.4e-01
—
—
—
—
—
1.5e+00
cases:0.89%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.61%
5
19
555
5406
—
—
—
—
—
15
32
530
5192
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
1.5e+00
—
—
—
—
—
1.3e+00
cases:1.96%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.34%
11
24
549
5401
—
—
—
—
—
7
18
538
5206
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
1.5e+00
—
—
—
—
—
1.1e+00
cases:1.79%
controls:0.41%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.57%
10
22
550
5403
—
—
—
—
—
9
30
536
5194
Neurology
13 [38004458]
13 [38004458]
7.8e-01
8.4e-01
—
—
1.8e+00
7.7e-01
7.0e-01
cases:6.79%
controls:3.23%
cases:3.04%
controls:1.33%
—
—
—
—
cases:1.07%
controls:0.18%
cases:3.06%
controls:1.44%
cases:8.44%
controls:4.36%
38
175
522
5250
17
72
543
5353
—
—
6
10
554
5413
17
77
538
5286
46
228
499
4996
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
-1.0e+50
-1.0e+50
—
—
—
—
1.5e+00
cases:0.00%
controls:0.31%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.52%
0
17
560
5408
0
6
560
5419
—
—
—
—
12
27
533
5197
Neurosurgery
14 [38004459]
14 [38004459]
1.0e+00
—
—
—
—
1.6e+00
1.5e+00
cases:2.14%
controls:0.77%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.22%
cases:3.67%
controls:0.88%
12
42
548
5383
—
—
—
—
6
12
549
5351
20
46
525
5178
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.48%
—
—
—
—
—
—
11
25
534
5199
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
9.5e-01
1.4e+00
—
—
—
1.5e+00
1.5e+00
cases:1.61%
controls:0.63%
cases:0.89%
controls:0.22%
—
—
—
—
—
—
cases:0.90%
controls:0.21%
cases:2.57%
controls:0.61%
9
34
551
5391
5
12
555
5413
—
—
—
5
11
550
5352
14
32
531
5192
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
6.4e-01
3.3e-01
—
—
—
5.2e-01
7.7e-01
cases:7.68%
controls:4.20%
cases:2.86%
controls:2.06%
—
—
—
—
—
—
cases:4.14%
controls:2.50%
cases:12.66%
controls:6.28%
43
228
517
5197
16
112
544
5313
—
—
—
23
134
532
5229
69
328
476
4896
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
11572-5 [3021614]
1.3e+00
1.6e+00
—
—
—
—
1.4e+00
cases:1.61%
controls:0.46%
cases:1.07%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.59%
9
25
551
5400
6
12
554
5413
—
—
—
—
13
31
532
5193
indometacin
C01EB03 [21600365]
C01EB03 [21600365]
9.4e-01
—
—
—
—
—
1.4e+00
cases:0.89%
controls:0.35%
—
—
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.59%
5
19
555
5406
—
—
—
—
—
13
31
532
5193
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
7.1e-01
-1.0e+50
—
—
—
—
1.4e+00
cases:0.89%
controls:0.44%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.59%
5
24
555
5401
0
6
560
5419
—
—
—
—
13
31
532
5193
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
1.3e+00
—
—
—
—
—
1.4e+00
cases:1.61%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.46%
9
24
551
5401
—
—
—
—
—
10
24
535
5200
clobetasol
D07AD01 [21602141]
D07AD01 [21602141]
1.4e+00
—
—
—
—
—
9.1e-01
cases:2.14%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:1.13%
12
30
548
5395
—
—
—
—
—
15
59
530
5165
mometasone; nasal
R01AD09 [21605051]
R01AD09 [21605051]
6.3e-01
1.7e-01
—
—
—
5.6e-01
7.4e-01
cases:7.32%
controls:4.04%
cases:1.96%
controls:1.66%
—
—
—
—
—
—
cases:3.42%
controls:1.98%
cases:9.72%
controls:4.90%
41
219
519
5206
11
90
549
5335
—
—
—
19
106
536
5257
53
256
492
4968
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
1.3e+00
1.1e+00
—
—
—
1.3e+00
3.0e-01
cases:2.14%
controls:0.57%
cases:1.25%
controls:0.42%
—
—
—
—
—
—
cases:0.90%
controls:0.24%
cases:1.83%
controls:1.36%
12
31
548
5394
7
23
553
5402
—
—
—
5
13
550
5350
10
71
535
5153
Other medical or dental certificate
WZA90 [2001310883]
WZA90 [2001310883]
1.3e+00
—
—
—
—
—
1.0e+00
cases:1.96%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
cases:2.57%
controls:0.96%
11
29
549
5396
—
—
—
—
—
14
50
531
5174
Audiology
64 [38004489]
64 [38004489]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.56%
—
—
—
—
—
—
11
29
534
5195
Shoulder symptom/complaint
L08 [2002000632]
L08 [2002000632]
1.7e+00
—
—
—
—
—
1.3e+00
cases:1.25%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:2.75%
controls:0.78%
7
12
553
5413
—
—
—
—
—
15
41
530
5183
fluticasone furoate
R03BA09 [45893496]
R03BA09 [45893496]
9.0e-01
5.2e-01
—
—
—
—
1.2e+00
cases:2.50%
controls:1.03%
cases:0.89%
controls:0.53%
—
—
—
—
—
—
—
—
cases:4.77%
controls:1.42%
14
56
546
5369
5
29
555
5396
—
—
—
—
26
74
519
5150
pseudoephedrine, combinations; oral
R01BA52 [21603213]
R01BA52 [21603213]
6.7e-01
4.4e-01
—
—
—
3.6e-01
5.8e-01
cases:9.29%
controls:5.00%
cases:3.21%
controls:2.10%
—
—
—
—
—
—
cases:3.24%
controls:2.29%
cases:14.31%
controls:8.54%
52
271
508
5154
18
114
542
5311
—
—
—
18
123
537
5240
78
446
467
4778
pseudoephedrine; oral
R01BA02 [21603210]
R01BA02 [21603210]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.57%
controls:0.77%
—
—
—
—
—
—
14
40
531
5184
montelukast; oral
R03DC03 [21603356]
R03DC03 [21603356]
9.8e-01
9.4e-01
—
—
-1.0e+50
7.5e-01
1.2e+00
cases:2.32%
controls:0.88%
cases:0.89%
controls:0.35%
—
—
—
—
cases:0.00%
controls:0.18%
cases:0.90%
controls:0.43%
cases:3.85%
controls:1.19%
13
48
547
5377
5
19
555
5406
—
—
0
10
560
5413
5
23
550
5340
21
62
524
5162
fluticasone; inhalant
R03BA05 [21603288]
R03BA05 [21603288]
9.0e-01
4.5e-01
—
—
—
—
1.2e+00
cases:2.68%
controls:1.11%
cases:0.89%
controls:0.57%
—
—
—
—
—
—
—
—
cases:4.95%
controls:1.57%
15
60
545
5365
5
31
555
5394
—
—
—
—
27
82
518
5142
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
1.2e+00
1.1e+00
—
—
—
7.3e-01
5.5e-01
cases:2.86%
controls:0.92%
cases:1.07%
controls:0.37%
—
—
—
—
—
—
cases:1.08%
controls:0.52%
cases:3.67%
controls:2.14%
16
50
544
5375
6
20
554
5405
—
—
—
6
28
549
5335
20
112
525
5112
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
8.1e-01
7.7e-01
—
—
—
6.6e-01
1.1e+00
cases:1.61%
controls:0.72%
cases:1.07%
controls:0.50%
—
—
—
—
—
—
cases:1.08%
controls:0.56%
cases:4.04%
controls:1.36%
9
39
551
5386
6
27
554
5398
—
—
—
6
30
549
5333
22
71
523
5153
beclometasone; nasal
R01AD01 [21605043]
R01AD01 [21605043]
9.4e-01
—
—
—
—
—
1.1e+00
cases:2.50%
controls:1.00%
—
—
—
—
—
—
—
—
—
—
cases:3.30%
controls:1.11%
14
54
546
5371
—
—
—
—
—
18
58
527
5166
tamsulosin; oral
G04CA02 [21602669]
G04CA02 [21602669]
5.7e-01
—
—
—
—
—
1.1e+00
cases:1.07%
controls:0.61%
—
—
—
—
—
—
—
—
—
—
cases:2.57%
controls:0.86%
6
33
554
5392
—
—
—
—
—
14
45
531
5179
terbutaline; inhalant
R03AC03 [21603257]
R03AC03 [21603257]
8.3e-01
4.5e-01
—
—
—
9.6e-01
1.1e+00
cases:2.50%
controls:1.11%
cases:0.89%
controls:0.57%
—
—
—
—
—
—
cases:1.44%
controls:0.56%
cases:3.85%
controls:1.32%
14
60
546
5365
5
31
555
5394
—
—
—
8
30
547
5333
21
69
524
5155
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
9.2e-01
1.0e+00
—
—
—
5.9e-01
1.1e+00
cases:3.04%
controls:1.24%
cases:1.25%
controls:0.44%
—
—
—
—
—
—
cases:0.90%
controls:0.50%
cases:4.59%
controls:1.59%
17
67
543
5358
7
24
553
5401
—
—
—
5
27
550
5336
25
83
520
5141
itraconazole; oral, parenteral
J02AC02 [21603081]
J02AC02 [21603081]
1.1e+00
—
—
—
—
—
1.1e+00
cases:2.14%
controls:0.76%
—
—
—
—
—
—
—
—
—
—
cases:3.85%
controls:1.36%
12
41
548
5384
—
—
—
—
—
21
71
524
5153
ambroxol; oral
R05CB06 [21603385]
R05CB06 [21603385]
1.0e+00
—
—
—
—
—
1.0e+00
cases:1.07%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
cases:2.57%
controls:0.92%
6
21
554
5404
—
—
—
—
—
14
48
531
5176
Lumbago with sciatica
M54.4 [45553205]
M54.4 [45553205]
1.1e+00
—
—
—
—
—
1.0e+00
cases:1.61%
controls:0.52%
—
—
—
—
—
—
—
—
—
—
cases:2.57%
controls:0.92%
9
28
551
5397
—
—
—
—
—
14
48
531
5176
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
5.1e-01
6.3e-01
—
—
—
8.1e-01
1.0e+00
cases:4.46%
controls:2.73%
cases:2.32%
controls:1.25%
—
—
—
—
—
—
cases:2.52%
controls:1.14%
cases:7.89%
controls:2.93%
25
148
535
5277
13
68
547
5357
—
—
—
14
61
541
5302
43
153
502
5071
betamethasone
S02BA07 [21605169]
S02BA07 [21605169]
4.7e-01
6.7e-01
—
—
—
2.5e-01
1.0e+00
cases:3.39%
controls:2.14%
cases:1.96%
controls:1.01%
—
—
—
—
—
—
cases:1.62%
controls:1.27%
cases:9.91%
controls:3.81%
19
116
541
5309
11
55
549
5370
—
—
—
9
68
546
5295
54
199
491
5025
betamethasone
C05AA05 [21601610]
C05AA05 [21601610]
4.7e-01
6.7e-01
—
—
—
2.5e-01
1.0e+00
cases:3.39%
controls:2.14%
cases:1.96%
controls:1.01%
—
—
—
—
—
—
cases:1.62%
controls:1.27%
cases:9.91%
controls:3.81%
19
116
541
5309
11
55
549
5370
—
—
—
9
68
546
5295
54
199
491
5025
betamethasone
D07AC01 [21602120]
D07AC01 [21602120]
4.7e-01
6.7e-01
—
—
—
2.5e-01
1.0e+00
cases:3.39%
controls:2.14%
cases:1.96%
controls:1.01%
—
—
—
—
—
—
cases:1.62%
controls:1.27%
cases:9.91%
controls:3.81%
19
116
541
5309
11
55
549
5370
—
—
—
9
68
546
5295
54
199
491
5025
betamethasone
A07EA04 [21600656]
A07EA04 [21600656]
4.7e-01
6.7e-01
—
—
—
2.5e-01
1.0e+00
cases:3.39%
controls:2.14%
cases:1.96%
controls:1.01%
—
—
—
—
—
—
cases:1.62%
controls:1.27%
cases:9.91%
controls:3.81%
19
116
541
5309
11
55
549
5370
—
—
—
9
68
546
5295
54
199
491
5025
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
5.1e-01
—
—
—
—
—
9.7e-01
cases:1.07%
controls:0.65%
—
—
—
—
—
—
—
—
—
—
cases:2.94%
controls:1.13%
6
35
554
5390
—
—
—
—
—
16
59
529
5165
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
1.2e+00
1.4e+00
—
—
—
8.1e-01
9.7e-01
cases:1.79%
controls:0.57%
cases:1.61%
controls:0.41%
—
—
—
—
—
—
cases:1.08%
controls:0.48%
cases:2.94%
controls:1.13%
10
31
550
5394
9
22
551
5403
—
—
—
6
26
549
5337
16
59
529
5165
Urology
34 [38004474]
34 [38004474]
5.2e-01
7.0e-01
—
—
—
1.3e+00
9.7e-01
cases:1.61%
controls:0.96%
cases:1.07%
controls:0.53%
—
—
—
—
—
—
cases:1.62%
controls:0.43%
cases:3.85%
controls:1.49%
9
52
551
5373
6
29
554
5396
—
—
—
9
23
546
5340
21
78
524
5146
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
7.9e-01
—
—
—
1.0e+50
9.4e-01
9.4e-01
cases:1.25%
controls:0.57%
—
—
—
—
—
—
cases:1.07%
controls:0.00%
cases:0.90%
controls:0.35%
cases:3.30%
controls:1.32%
7
31
553
5394
—
—
—
6
0
554
5423
5
19
550
5344
18
69
527
5155
Internal Medicine
11 [38004456]
11 [38004456]
4.7e-01
5.1e-01
—
—
—
4.0e-01
4.5e-01
cases:13.93%
controls:9.22%
cases:5.71%
controls:3.50%
—
—
—
—
—
—
cases:5.77%
controls:3.93%
cases:17.25%
controls:11.70%
78
500
482
4925
32
190
528
5235
—
—
—
32
211
523
5152
94
611
451
4613
clarithromycin; oral, parenteral
J01FA09 [21602977]
J01FA09 [21602977]
3.4e-01
—
—
—
-1.0e+50
8.4e-01
9.0e-01
cases:3.04%
controls:2.18%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.90%
controls:0.39%
cases:5.32%
controls:2.24%
17
118
543
5307
—
—
—
0
6
560
5417
5
21
550
5342
29
117
516
5107
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
7.0e-01
1.0e+00
—
—
—
6.1e-01
8.7e-01
cases:2.50%
controls:1.25%
cases:1.61%
controls:0.57%
—
—
—
—
—
—
cases:1.26%
controls:0.69%
cases:5.14%
controls:2.22%
14
68
546
5357
9
31
551
5394
—
—
—
7
37
548
5326
28
116
517
5108
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.4e-01
8.9e-01
—
—
—
1.1e+00
8.6e-01
cases:1.79%
controls:1.16%
cases:1.07%
controls:0.44%
—
—
—
—
—
—
cases:1.26%
controls:0.41%
cases:4.04%
controls:1.74%
10
63
550
5362
6
24
554
5401
—
—
—
7
22
548
5341
22
91
523
5133
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
8.6e-01
—
—
—
-1.0e+50
2.2e-01
5.2e-01
cases:3.93%
controls:1.70%
—
—
—
—
—
—
cases:0.00%
controls:0.42%
cases:1.44%
controls:1.16%
cases:4.59%
controls:2.78%
22
92
538
5333
—
—
—
0
23
560
5400
8
62
547
5301
25
145
520
5079
clindamycin; vaginal
G01AA10 [21602372]
G01AA10 [21602372]
4.5e-01
—
—
—
—
—
8.6e-01
cases:2.32%
controls:1.49%
—
—
—
—
—
—
—
—
—
—
cases:3.85%
controls:1.67%
13
81
547
5344
—
—
—
—
—
21
87
524
5137
Gastroenterology
10 [38004455]
10 [38004455]
2.2e-01
—
—
—
—
—
8.6e-01
cases:1.61%
controls:1.29%
—
—
—
—
—
—
—
—
—
—
cases:3.67%
controls:1.59%
9
70
551
5355
—
—
—
—
—
20
83
525
5141
Cardiology
6 [38004451]
6 [38004451]
5.4e-01
7.0e-01
—
—
—
4.3e-01
8.6e-01
cases:2.32%
controls:1.36%
cases:1.25%
controls:0.63%
—
—
—
—
—
—
cases:1.08%
controls:0.71%
cases:4.95%
controls:2.16%
13
74
547
5351
7
34
553
5391
—
—
—
6
38
549
5325
27
113
518
5111
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
8.4e-01
7.4e-01
—
—
—
8.3e-01
5.5e-01
cases:4.46%
controls:1.97%
cases:1.61%
controls:0.77%
—
—
—
—
—
—
cases:1.44%
controls:0.63%
cases:4.59%
controls:2.70%
25
107
535
5318
9
42
551
5383
—
—
—
8
34
547
5329
25
141
520
5083
other preparations, combinations; ointment
C05AX03 [21601631]
C05AX03 [21601631]
-4.7e-02
—
-1.0e+50
—
—
—
8.2e-01
cases:1.25%
controls:1.31%
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:4.04%
controls:1.82%
7
71
553
5354
—
0
8
560
5417
—
—
—
22
95
523
5129
Psychiatry
26 [38004469]
26 [38004469]
3.2e-01
1.3e-01
—
—
—
3.0e-01
7.5e-01
cases:3.93%
controls:2.89%
cases:1.61%
controls:1.42%
—
—
—
—
—
—
cases:1.98%
controls:1.47%
cases:7.16%
controls:3.50%
22
157
538
5268
9
77
551
5348
—
—
—
11
79
544
5284
39
183
506
5041
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
7.4e-01
5.4e-01
—
—
—
4.7e-01
3.5e-01
cases:5.36%
controls:2.64%
cases:2.50%
controls:1.47%
—
—
—
—
—
—
cases:2.52%
controls:1.58%
cases:7.16%
controls:5.15%
30
143
530
5282
14
80
546
5345
—
—
—
14
85
541
5278
39
269
506
4955
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
5.1e-01
2.2e-01
-1.0e+50
—
—
—
7.3e-01
cases:3.39%
controls:2.06%
cases:0.89%
controls:0.72%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:6.06%
controls:3.02%
19
112
541
5313
5
39
555
5386
0
5
560
5420
—
—
—
33
158
512
5066
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
H03AA01 [21602754]
2.0e-01
2.0e-01
—
—
—
2.9e-01
7.2e-01
cases:3.04%
controls:2.49%
cases:3.04%
controls:2.51%
—
—
—
—
—
—
cases:3.42%
controls:2.59%
cases:7.16%
controls:3.60%
17
135
543
5290
17
136
543
5289
—
—
—
19
139
536
5224
39
188
506
5036
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
7.1e-01
6.7e-01
—
—
—
6.0e-01
4.4e-01
cases:5.36%
controls:2.71%
cases:1.79%
controls:0.92%
—
—
—
—
—
—
cases:1.98%
controls:1.10%
cases:6.61%
controls:4.36%
30
147
530
5278
10
50
550
5375
—
—
—
11
59
544
5304
36
228
509
4996
mometasone
D07AC13 [21602132]
D07AC13 [21602132]
7.4e-01
2.6e-01
—
—
—
6.7e-01
7.0e-01
cases:4.29%
controls:2.08%
cases:1.07%
controls:0.83%
—
—
—
—
—
—
cases:1.62%
controls:0.84%
cases:5.69%
controls:2.91%
24
113
536
5312
6
45
554
5380
—
—
—
9
45
546
5318
31
152
514
5072
antibiotics in combination with other drugs
S01AA20 [21603571]
S01AA20 [21603571]
4.2e-01
3.0e-02
-1.0e+50
—
—
1.7e-01
6.9e-01
cases:3.04%
controls:2.01%
cases:0.89%
controls:0.87%
cases:0.00%
controls:0.13%
—
—
—
—
cases:0.90%
controls:0.76%
cases:6.06%
controls:3.14%
17
109
543
5316
5
47
555
5378
0
7
560
5418
—
—
5
41
550
5322
33
164
512
5060
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
6.3e-01
4.7e-01
—
—
—
6.0e-01
6.8e-01
cases:5.18%
controls:2.82%
cases:1.61%
controls:1.01%
—
—
—
—
—
—
cases:1.62%
controls:0.90%
cases:7.89%
controls:4.17%
29
153
531
5272
9
55
551
5370
—
—
—
9
48
546
5315
43
218
502
5006
combinations of corticosteroids
D07XB30 [21602188]
D07XB30 [21602188]
3.2e-01
3.2e-01
—
—
-1.0e+50
5.2e-01
6.4e-01
cases:6.25%
controls:4.63%
cases:2.50%
controls:1.82%
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.06%
controls:1.85%
cases:12.29%
controls:6.85%
35
251
525
5174
14
99
546
5326
—
—
0
13
560
5410
17
99
538
5264
67
358
478
4866
combinations of corticosteroids
D07AB30 [21602118]
D07AB30 [21602118]
3.2e-01
3.2e-01
—
—
-1.0e+50
5.2e-01
6.4e-01
cases:6.25%
controls:4.63%
cases:2.50%
controls:1.82%
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.06%
controls:1.85%
cases:12.29%
controls:6.85%
35
251
525
5174
14
99
546
5326
—
—
0
13
560
5410
17
99
538
5264
67
358
478
4866
cetirizine; oral
R06AE07 [21603497]
R06AE07 [21603497]
4.8e-01
3.4e-01
—
—
—
7.0e-01
6.0e-01
cases:6.96%
controls:4.44%
cases:2.86%
controls:2.05%
—
—
—
—
—
—
cases:4.50%
controls:2.29%
cases:9.72%
controls:5.59%
39
241
521
5184
16
111
544
5314
—
—
—
25
123
530
5240
53
292
492
4932
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
4.4e-01
4.1e-01
—
—
—
4.6e-01
4.9e-01
cases:7.86%
controls:5.20%
cases:3.93%
controls:2.65%
—
—
—
—
—
—
cases:4.14%
controls:2.67%
cases:13.94%
controls:9.05%
44
282
516
5143
22
144
538
5281
—
—
—
23
143
532
5220
76
473
469
4751
phenoxymethylpenicillin; oral
J01CE02 [21602842]
J01CE02 [21602842]
3.8e-01
2.0e-01
—
—
—
4.5e-01
4.5e-01
cases:10.36%
controls:7.34%
cases:3.21%
controls:2.64%
—
—
—
—
—
—
cases:3.96%
controls:2.57%
cases:13.94%
controls:9.38%
58
398
502
5027
18
143
542
5282
—
—
—
22
138
533
5225
76
490
469
4734
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
J01CE10 [21602850]
3.8e-01
2.0e-01
—
—
—
4.5e-01
4.5e-01
cases:10.36%
controls:7.34%
cases:3.21%
controls:2.64%
—
—
—
—
—
—
cases:3.96%
controls:2.57%
cases:13.94%
controls:9.38%
58
398
502
5027
18
143
542
5282
—
—
—
22
138
533
5225
76
490
469
4734
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
3.9e-01
5.5e-01
1.3e+00
—
—
5.0e-01
4.3e-01
cases:15.18%
controls:10.76%
cases:6.25%
controls:3.71%
cases:0.89%
controls:0.24%
—
—
—
—
cases:5.95%
controls:3.71%
cases:19.27%
controls:13.50%
85
584
475
4841
35
201
525
5224
5
13
555
5412
—
—
33
199
522
5164
105
705
440
4519
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
enalapril and diuretics
C09BA02 [21601804]
C09BA02 [21601804]
9.3e-01
9.4e-01
—
—
—
8.4e-01
1.6e-01
cases:1.07%
controls:0.42%
cases:0.89%
controls:0.35%
—
—
—
—
—
—
cases:0.90%
controls:0.39%
cases:0.92%
controls:0.78%
6
23
554
5402
5
19
555
5406
—
—
—
5
21
550
5342
5
41
540
5183
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.4e-01
2.1e-01
4.5e-01
—
6.0e-01
3.7e-01
5.4e-02
cases:7.86%
controls:6.93%
cases:6.79%
controls:5.57%
cases:1.61%
controls:1.03%
—
—
cases:1.43%
controls:0.79%
cases:8.11%
controls:5.74%
cases:14.68%
controls:14.01%
44
376
516
5049
38
302
522
5123
9
56
551
5369
—
8
43
552
5380
45
308
510
5055
80
732
465
4492
ephedrine; oral
R03CA02 [21603304]
R03CA02 [21603304]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.31%
—
—
—
—
—
—
5
16
540
5208
Haemorrhage of anus and rectum
K62.5 [45596339]
K62.5 [45596339]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
9
545
5215
nedocromil; inhalant
R03BC03 [21603299]
R03BC03 [21603299]
—
-1.0e+50
—
—
—
—
9.2e-01
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.44%
—
0
6
560
5419
—
—
—
—
6
23
539
5201
Acute frontal sinusitis
J01.1 [45586656]
J01.1 [45586656]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
560
5419
—
—
—
—
—
—
Major dressing of wound of skin of trunk
QBB10 [2001309842]
QBB10 [2001309842]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
5
545
5219
Postmenopausal atrophic vaginitis
N95.2 [45582430]
N95.2 [45582430]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
545
5218
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
9.7e-01
—
—
—
—
8.4e-01
5.3e-01
cases:2.68%
controls:1.03%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.39%
cases:2.75%
controls:1.65%
15
56
545
5369
—
—
—
—
5
21
550
5342
15
86
530
5138
Gestational [pregnancy-induced] hypertension
O13 [45539091]
O13 [45539091]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
560
5414
—
—
—
—
—
—
cinnarizine; oral
N07CA02 [21604834]
N07CA02 [21604834]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
—
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
N05AB03 [21604502]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.29%
cases:0.00%
controls:0.18%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
0
16
560
5409
0
10
560
5415
—
—
—
0
14
555
5349
—
Benign neoplasm: Caecum
D12.0 [45586086]
D12.0 [45586086]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
5
545
5219
Streptococcus pyogenes Ag [Presence] in Throat
18481-2 [3033319]
18481-2 [3033319]
—
9.4e-01
—
—
—
-1.0e+50
8.3e-01
—
—
cases:0.89%
controls:0.35%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:2.20%
controls:0.98%
—
5
19
555
5406
—
—
—
0
9
555
5354
12
51
533
5173
Lesion of ulnar nerve
G56.2 [45595951]
G56.2 [45595951]
2.3e+00
—
—
—
—
—
—
cases:0.89%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
5
5
555
5420
—
—
—
—
—
—
Pediatric Endocrinology
OMOP4822030 [45756809]
OMOP4822030 [45756809]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
0
12
560
5413
0
5
560
5420
—
—
—
—
—
Deflected nasal septum[DEFORMATIO SEPTI NASI]
4700A [2000403900]
4700A [2000403900]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
560
5418
—
—
—
—
—
—
Prick test
37968009 [4242723]
37968009 [4242723]
1.5e+00
—
—
—
—
—
—
cases:0.89%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
5
11
555
5414
—
—
—
—
—
—
allopurinol; oral, parenteral
M04AA01 [21604131]
M04AA01 [21604131]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.50%
—
—
—
—
—
—
8
26
537
5198
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
0
7
560
5418
—
—
—
—
0
6
555
5357
—
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
560
5415
—
—
—
—
—
—
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
0
6
560
5419
0
5
560
5420
—
—
—
—
0
5
545
5219
Excessive ear wax
H81 [2002000536]
H81 [2002000536]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
0
6
560
5419
—
—
—
0
5
555
5358
—
Health check-up of pregnant person
SPAT1379 [2001700479]
SPAT1379 [2001700479]
2.1e-01
-1.0e+50
—
—
—
—
5.6e-01
cases:1.07%
controls:0.87%
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.63%
6
47
554
5378
0
16
560
5409
—
—
—
—
6
33
539
5191
Acute suppurative otitis media
H66.0 [45572040]
H66.0 [45572040]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.23%
—
—
—
—
—
—
5
12
540
5212
Alcohol dependence currently independent
F10.20 [2000501677]
F10.20 [2000501677]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
9
545
5215
ketorolac
S01BC05 [21603643]
S01BC05 [21603643]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
560
5416
—
—
—
—
—
—
Upper respiratory infection acute
R74 [2002000942]
R74 [2002000942]
2.4e-01
—
—
—
-1.0e+50
5.6e-01
4.5e-01
cases:2.14%
controls:1.70%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:1.26%
controls:0.73%
cases:4.04%
controls:2.60%
12
92
548
5333
—
—
—
0
6
560
5417
7
39
548
5324
22
136
523
5088
Vascular Surgery
77 [38004496]
77 [38004496]
—
—
—
—
—
—
8.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.63%
—
—
—
—
—
—
8
33
537
5191
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
0
5
560
5420
—
—
—
—
0
5
545
5219
Insertion of (intrauterine) contraceptive device
Z30.1 [45537626]
Z30.1 [45537626]
6.3e-01
—
—
—
—
-1.0e+50
4.7e-01
cases:1.07%
controls:0.57%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
cases:1.10%
controls:0.69%
6
31
554
5394
—
—
—
—
0
11
555
5352
6
36
539
5188
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30522-7 [3010156]
30522-7 [3010156]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
—
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
41645-3 [3033705]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
5
545
5219
chlorpromazine; oral, parenteral, rectal
N05AA01 [21604492]
N05AA01 [21604492]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
545
5218
Preventive oral health care, short
SCA01 [2001310302]
SCA01 [2001310302]
-2.1e-02
8.9e-01
—
—
—
—
6.0e-01
cases:1.61%
controls:1.64%
cases:0.89%
controls:0.37%
—
—
—
—
—
—
—
—
cases:3.30%
controls:1.84%
9
89
551
5336
5
20
555
5405
—
—
—
—
18
96
527
5128
Skin infection other
S76 [2002001040]
S76 [2002001040]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
11
545
5213
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
—
—
—
—
—
—
6.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.67%
—
—
—
—
—
—
7
35
538
5189
Treatment-related counselling outside office
SPAT1249 [2001700350]
SPAT1249 [2001700350]
5.4e-01
6.4e-01
—
—
—
5.0e-01
2.0e-01
cases:3.04%
controls:1.79%
cases:1.43%
controls:0.76%
—
—
—
—
—
—
cases:1.62%
controls:0.99%
cases:3.85%
controls:3.18%
17
97
543
5328
8
41
552
5384
—
—
—
9
53
546
5310
21
166
524
5058
Antenatal screening
243787009 [4087235]
243787009 [4087235]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.20%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
0
11
560
5414
0
9
560
5416
—
—
—
0
8
555
5355
—
Alcohol dependence continuous use
F10.25 [2000501682]
F10.25 [2000501682]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
560
5417
—
—
—
—
—
—
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
—
—
Other fall from one level to another
W17 [45756255]
W17 [45756255]
1.5e+00
—
—
—
—
—
-1.0e+50
cases:0.89%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
5
11
555
5414
—
—
—
—
—
0
8
545
5216
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
22587-0 [3019832]
—
—
—
—
—
—
8.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.98%
—
—
—
—
—
—
12
51
533
5173
Calculus of gallbladder with acute cholecystitis
K80.0 [45586735]
K80.0 [45586735]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
545
5218
desonide
D07AB08 [21602112]
D07AB08 [21602112]
9.2e-01
-1.0e+50
—
—
—
—
6.3e-01
cases:1.43%
controls:0.57%
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.69%
8
31
552
5394
0
11
560
5414
—
—
—
—
7
36
538
5188
Open wound of other parts of foot
S91.3 [45599027]
S91.3 [45599027]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
560
5418
—
—
—
—
—
—
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
560
5414
—
—
—
—
—
—
Curettage of body of uterus
LCA10 [2001306552]
LCA10 [2001306552]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
5
545
5219
Iron deficiency
E61.1 [45595821]
E61.1 [45595821]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
—
—
Monitoring of normal pregnancy
SPAT1196 [2001700297]
SPAT1196 [2001700297]
—
-1.0e+50
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.09%
—
—
—
—
cases:0.00%
controls:0.22%
cases:0.00%
controls:0.38%
—
0
9
560
5416
0
5
560
5420
—
—
0
12
555
5351
0
20
545
5204
Chronic ischaemic heart disease, unspecified
I25.9 [45552784]
I25.9 [45552784]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
0
9
560
5416
—
—
—
—
—
0
10
545
5214
ganirelix; parenteral
H01CC01 [21602720]
H01CC01 [21602720]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.00%
controls:0.15%
—
0
8
560
5417
—
—
—
0
5
555
5358
0
8
545
5216
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
6357-8 [3024950]
2.4e-01
—
-1.0e+50
—
—
7.0e-01
6.2e-01
cases:1.43%
controls:1.12%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
cases:0.90%
controls:0.45%
cases:2.39%
controls:1.30%
8
61
552
5364
—
0
6
560
5419
—
—
5
24
550
5339
13
68
532
5156
Cervical dilation and drainage with suction
8511 [2000101376]
8511 [2000101376]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
9
545
5215
Female infertility of other origin
N97.8 [45596891]
N97.8 [45596891]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
0
11
560
5414
—
—
—
—
—
0
5
545
5219
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
12
545
5212
Adhesive capsulitis of shoulder
M75.0 [45533931]
M75.0 [45533931]
-1.0e+50
—
—
—
—
—
1.2e+00
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.27%
0
5
560
5420
—
—
—
—
—
5
14
540
5210
Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24111-7 [3011371]
24111-7 [3011371]
—
—
—
—
—
—
9.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:0.71%
—
—
—
—
—
—
10
37
535
5187
Ventricular premature depolarization
I49.3 [45538386]
I49.3 [45538386]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
0
10
560
5415
—
—
—
—
—
0
15
545
5209
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
F32.3 [45600739]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
560
5419
—
—
—
—
—
—
Hearing loss, unspecified
H91.9 [45547996]
H91.9 [45547996]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
545
5218
Celiac disease serology panel - Serum
94494-2 [36660697]
94494-2 [36660697]
1.1e+00
-1.0e+50
—
—
—
—
—
cases:0.89%
controls:0.29%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
5
16
555
5409
0
5
560
5420
—
—
—
—
—
Primary total prosthetic replacement of hip joint not using cement
NFB30 [2001307921]
NFB30 [2001307921]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.00%
—
—
—
—
—
—
5
0
540
5224
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
—
—
—
—
—
-1.0e+50
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:1.10%
controls:0.29%
—
—
—
—
—
0
5
555
5358
6
15
539
5209
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
SPAT1306 [2001700407]
7.5e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.89%
controls:0.42%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
5
23
555
5402
0
9
560
5416
—
—
—
0
7
555
5356
—
Testosterone [Moles/volume] in Serum or Plasma
14913-8 [3017446]
14913-8 [3017446]
—
—
—
—
—
—
8.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.56%
—
—
—
—
—
—
7
29
538
5195
Pregnancy symptom/complaint other
W29 [2002001222]
W29 [2002001222]
-1.0e+50
—
—
—
-1.0e+50
—
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:0.00%
controls:0.11%
0
7
560
5418
—
—
—
0
5
560
5418
—
0
6
545
5218
Transient cerebral ischaemic attack, unspecified
G45.9 [45542892]
G45.9 [45542892]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
0
6
555
5357
—
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
560
5419
—
—
—
—
—
—
hypromellose
S01KA02 [21605115]
S01KA02 [21605115]
1.1e+00
—
—
—
—
1.6e+00
6.3e-01
cases:1.07%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.19%
cases:1.28%
controls:0.69%
6
19
554
5406
—
—
—
—
5
10
550
5353
7
36
538
5188
Embedded teeth
K01.0 [45548133]
K01.0 [45548133]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
—
—
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.25%
—
—
—
—
—
—
6
13
539
5211
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
2.2e-01
-1.0e+50
—
—
—
-1.0e+50
2.6e-01
cases:0.89%
controls:0.72%
cases:0.00%
controls:0.24%
—
—
—
—
—
—
cases:0.00%
controls:0.34%
cases:1.83%
controls:1.42%
5
39
555
5386
0
13
560
5412
—
—
—
0
18
555
5345
10
74
535
5150
Primary total prosthetic replacement of knee joint without patellar part
NGB20 [2001308094]
NGB20 [2001308094]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.00%
—
—
—
—
—
—
7
0
538
5224
tiaprofenic acid; oral, rectal
M01AE11 [21603977]
M01AE11 [21603977]
1.9e+00
—
—
—
—
—
1.2e+00
cases:0.89%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.33%
5
7
555
5418
—
—
—
—
—
6
17
539
5207
chorionic gonadotrophin; parenteral
G03GA01 [21602599]
G03GA01 [21602599]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.36%
—
0
10
560
5415
—
—
—
0
9
555
5354
0
19
545
5205
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: occasional
SMOKING-1-1-2 [2002330117]
SMOKING-1-1-2 [2002330117]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
0
37
560
5388
0
14
560
5411
—
—
—
—
—
Other general examinations
Z00.8 [45581001]
Z00.8 [45581001]
-1.0e+50
-1.0e+50
—
—
—
—
1.4e+00
cases:0.00%
controls:0.22%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.23%
0
12
560
5413
0
7
560
5418
—
—
—
—
5
12
540
5212
Disorder of ligament
M24.2 [45557839]
M24.2 [45557839]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.00%
—
—
—
—
—
—
5
0
540
5224
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
7
545
5217
Counselling and guidance related to occupational health
SPAT1311 [2001700412]
SPAT1311 [2001700412]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
560
5417
—
—
—
—
—
—
hydrocortisone and antiseptics
D07BA04 [21602146]
D07BA04 [21602146]
—
—
—
—
—
—
8.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.94%
controls:1.34%
—
—
—
—
—
—
16
70
529
5154
Prothrombin time (PT)
5902-2 [3034426]
5902-2 [3034426]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
560
5420
—
—
—
—
—
—
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
4.7e-01
—
—
—
—
8.9e-01
4.2e-01
cases:1.61%
controls:1.01%
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.37%
cases:2.75%
controls:1.82%
9
55
551
5370
—
—
—
—
5
20
550
5343
15
95
530
5129
Caries limited to enamel
K02.0 [45576967]
K02.0 [45576967]
—
-1.0e+50
—
—
—
—
6.4e-02
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.28%
controls:1.21%
—
0
8
560
5417
—
—
—
—
7
63
538
5161
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
0
7
560
5418
—
—
—
—
—
0
9
545
5215
warfarin; oral, parenteral
B01AA03 [21600965]
B01AA03 [21600965]
4.0e-01
—
—
—
—
—
4.1e-01
cases:1.07%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:1.83%
controls:1.23%
6
39
554
5386
—
—
—
—
—
10
64
535
5160
Ultrasound examination of paranasal sinuses
SPAT1028 [2001700129]
SPAT1028 [2001700129]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.33%
—
—
—
—
—
—
5
17
540
5207
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
48
12.57
57.03
1.5
1.0
—
—
—
0
0
47
43
11.45
44.49
1.7
1.1
11297.85
12308.19
e6/l
0.06
33
31
223
924
2.85
37.18
1.3
1.1
3.41
1.54
u/ml
0.60
97
368
238
1038
2.73
35.83
1.4
1.2
25.80
17.91
iu/ml
0.86
65
272
301
1824
1.95
18.94
2.9
2.6
340.37
346.97
umol/l
0.56
267
1630
698
5539
1.98
18.86
5.3
3.4
11.51
11.67
mm/h
0.11
669
5140
476
3384
1.81
17.80
3.1
2.7
—
—
estimate
—
0
0
271
1671
1.87
15.69
1.8
1.7
0.97
1.33
mg/l
2.38
223
1295
724
6037
1.84
14.04
8.7
8.2
78.03
79.75
u/l
0.63
702
5743
64
229
2.92
13.52
1.3
1.9
2.46
7.89
iu/ml
1.70
17
60
342
2378
1.68
12.56
2.2
2.2
251.65
241.09
u/l
0.06
331
2255
357
2512
1.67
12.53
3.0
2.8
59.33
64.56
u/l
0.38
337
2333
262
1716
1.73
11.89
3.0
2.5
5.21
5.89
e6/l
0.28
245
1549
520
4059
1.62
11.84
4.6
3.4
0.00
5.61
estimate
1.07
111
823
389
2830
1.63
11.80
4.3
3.7
51.32
132.86
e6/l
1.91
305
1998
474
3623
1.62
11.72
14.2
13.8
1.24
1.24
inr
0.07
392
3029
521
4077
1.62
11.67
4.6
3.4
0.03
0.02
estimate
0.13
106
759
860
7727
2.19
11.63
19.5
14.5
23.72
27.28
mg/l
2.17
752
6151
584
4703
1.63
11.59
4.9
5.6
6.74
6.76
mmol/l
0.11
568
4470
353
2518
1.64
11.51
3.8
3.1
44.21
59.09
e6/l
0.34
292
1899
513
4014
1.60
11.38
4.5
3.4
0.00
0.00
estimate
0.50
108
822
460
3513
1.60
11.26
5.3
5.5
36.03
35.70
g/l
0.66
440
3312
117
604
2.07
11.10
3.8
2.7
67.58
65.62
ml/min/173m2
0.18
48
251
603
4942
1.60
10.71
5.2
4.1
3.33
965.66
e6/l
—
6
68
306
2169
1.61
9.93
3.5
3.0
0.21
0.53
e6/l
4.52
248
1570
530
4261
1.55
9.86
5.8
7.5
11.02
12.00
umol/l
0.77
512
4071
490
3905
1.53
9.25
7.4
7.9
1.21
1.21
mmol/l
0.52
440
3368
56
231
2.51
9.04
1.2
1.2
0.36
0.90
u/ml
—
9
14
539
4442
1.49
8.28
8.9
9.8
4.10
4.11
e9/l
0.02
483
3833
441
3495
1.49
8.20
6.4
7.2
1.21
1.21
mmol/l
0.70
420
3212
393
3048
1.49
8.10
4.2
3.6
32.75
57.89
ng/l
1.23
292
2158
271
1945
1.55
8.04
2.5
2.1
2.95
2.76
mg/l
0.54
241
1627
32
104
3.15
8.04
2.2
1.4
—
—
—
0
0
110
621
1.87
8.03
2.7
2.3
0.53
0.59
e6/l
0.09
105
593
297
2195
1.51
7.63
5.1
3.4
0.00
0.01
estimate
1.34
105
748
430
3434
1.46
7.46
2.6
2.3
74.96
76.48
nmol/l
0.58
404
3106
195
1327
1.59
7.21
3.1
2.8
1.06
0.99
e6/l
0.11
123
689
40
158
2.60
7.09
1.2
1.2
2.10
2.89
u/ml
—
6
27
156
1011
1.65
7.03
1.8
1.9
—
—
—
0
0
359
2798
1.46
6.93
3.8
3.3
7.48
7.81
mmol/l
0.69
324
2403
350
2715
1.46
6.93
4.3
4.0
17.82
9.23
mg/mmol
0.39
238
1709
872
8123
1.90
6.90
21.7
17.8
139.58
139.74
mmol/l
1.10
867
7934
387
3067
1.44
6.80
4.5
3.4
0.00
0.07
estimate
1.14
92
663
872
8141
1.87
6.59
22.1
18.0
4.00
3.98
mmol/l
1.27
866
7939
432
3517
1.42
6.44
3.5
2.8
125.98
147.66
ug/l
1.26
413
3278
190
1324
1.54
6.27
1.8
1.9
—
—
—
0
0
291
2219
1.45
6.16
1.7
1.7
20.77
19.98
nmol/l
0.38
262
1886
424
3465
1.40
6.07
2.1
2.0
94.74
94.19
pmol/l
0.09
251
1894
32
123
2.66
6.02
1.1
1.2
39.24
53.12
u/ml
—
5
16
677
6013
1.44
5.89
4.8
4.1
14.78
14.77
pmol/l
0.03
637
5516
817
7547
1.59
5.75
7.3
6.1
40.35
39.43
mmol/mol
1.91
782
7037
81
462
1.82
5.74
2.6
2.5
32.43
18.91
au/ml
—
10
49
144
962
1.59
5.69
1.8
1.9
—
—
—
0
0
75
425
1.83
5.44
1.3
1.3
64.40
59.37
au/ml
—
5
32
268
2057
1.42
5.36
4.1
4.1
93.00
89.28
%
1.71
261
2012
725
6576
1.43
5.18
22.2
18.4
13.71
13.60
%
1.43
718
6473
827
7700
1.57
5.18
17.8
14.3
80.80
80.94
ml/min/173m2
0.08
781
7115
234
1771
1.43
5.02
5.1
3.4
1.02
1.90
kg/l
0.50
160
1139
197
1458
1.44
4.75
1.4
1.5
2.29
2.50
g/l
0.97
131
903
38
178
2.18
4.71
1.7
1.7
—
—
—
0
0
784
7253
1.46
4.71
5.9
5.0
1.84
1.95
mu/l
1.79
749
6687
238
1829
1.40
4.64
2.7
2.4
—
—
—
0
0
40
194
2.11
4.56
1.5
1.3
—
—
—
0
0
45
233
1.98
4.32
1.6
1.6
—
—
—
0
0
151
1086
1.46
4.21
6.2
6.1
1.06
1.03
mmol/l
0.41
143
1004
328
2691
1.33
4.17
2.8
3.3
29.91
33.77
u/l
1.96
298
2554
92
597
1.60
4.12
1.4
1.4
—
—
—
0
0
72
439
1.69
4.11
2.9
3.4
1.84
1.76
mmol/l
0.05
51
334
30
139
2.20
3.86
2.4
2.1
273.26
7107.83
u/l
—
9
55
217
1690
1.37
3.84
1.3
1.3
1.63
1.97
u/ml
0.21
60
458
57
332
1.76
3.84
2.0
2.3
38.84
38.81
u/l
0.00
51
294
35
175
2.04
3.73
1.2
1.4
285.89
651.23
e6/l
0.35
27
133
280
2285
1.32
3.60
3.1
3.1
1008.35
1244.71
ng/l
0.58
245
1970
603
5447
1.29
3.53
3.7
3.3
48.84
51.64
u/l
0.40
578
5139
36
188
1.95
3.42
1.6
1.5
0.01
0.31
iu/ml
—
5
29
34
174
1.99
3.42
1.2
1.3
2.44
8.61
e6/l
0.87
25
130
164
1244
1.38
3.39
3.4
2.9
1.76
1.87
e6/l
0.09
92
600
124
899
1.44
3.32
2.0
2.4
241.50
153.87
ug/g
0.60
93
728
108
768
1.46
3.21
2.7
2.3
12.74
13.34
nmol/l
0.41
101
699
13
45
2.92
3.03
1.2
1.2
32.23
28.87
umol/l
0.39
13
40
64
415
1.58
2.93
1.4
1.5
—
—
—
0
0
324
2759
1.26
2.90
3.4
4.1
2.36
2.36
mmol/l
0.02
310
2531
199
1594
1.31
2.87
3.7
3.7
133.42
530.20
ng/l
3.75
153
1240
84
588
1.47
2.73
3.8
3.7
114.12
92.77
ng/l
0.46
76
510
199
1607
1.30
2.70
2.9
3.3
2.45
2.45
mmol/l
0.01
188
1468
87
624
1.43
2.50
3.3
3.5
1.23
1.23
mmol/l
0.13
74
524
9
26
3.48
2.48
1.0
1.0
—
—
—
0
0
79
561
1.45
2.41
1.3
1.6
—
—
—
0
0
34
200
1.73
2.31
1.4
1.4
7.86
9.22
u/l
0.32
26
160
259
2199
1.24
2.31
4.1
3.0
0.01
0.01
estimate
0.02
94
627
18
85
2.14
2.30
2.0
1.2
1.90
1.62
nmol/l
0.29
18
80
10
34
2.96
2.28
3.0
3.1
—
—
—
0
0
11
40
2.77
2.28
1.3
1.1
—
—
—
0
0
32
186
1.75
2.27
2.1
2.2
128.15
127.78
g/l
0.03
26
145
70
492
1.46
2.26
1.7
1.7
—
—
—
0
0
101
763
1.36
2.18
3.6
3.1
—
—
—
0
0
808
7736
1.30
2.17
5.5
4.9
6.06
5.96
mmol/l
1.36
768
7126
25
138
1.83
2.11
3.8
3.0
7.82
8.85
pmol/l
0.26
25
138
830
7986
1.31
2.07
5.4
5.0
4.56
4.67
mmol/l
2.57
791
7476
508
4654
1.20
2.03
2.8
2.8
—
—
—
0
0
11
44
2.52
2.01
2.2
2.0
—
—
—
0
0
840
8103
1.32
1.99
6.3
5.7
2.62
2.75
mmol/l
3.63
799
7555
31
187
1.68
1.96
2.3
2.4
82.62
148.16
ug/min
0.46
21
110
12
51
2.37
1.95
1.8
1.3
146.47
182.70
pmol/l
0.73
12
51
10
39
2.58
1.94
1.2
1.3
4.21
7.59
u/l
—
10
34
892
8689
1.44
1.94
29.2
22.0
251.55
248.53
e9/l
0.70
883
8475
869
8429
1.36
1.93
13.9
11.0
26.97
26.74
u/l
0.17
859
8179
23
128
1.82
1.91
1.1
1.1
1.48
2.40
u/ml
—
7
74
120
950
1.30
1.90
2.4
2.9
10.33
8.52
umol/l
0.26
106
846
62
442
1.43
1.89
2.0
3.8
4.47
4.50
pmol/l
0.09
52
401
892
8693
1.43
1.89
29.2
22.0
4.52
4.52
e12/l
0.11
880
8462
15
72
2.10
1.87
1.4
1.4
—
—
—
0
0
8
28
2.87
1.86
1.3
2.4
40.04
41.73
g/l
—
8
28
123
980
1.29
1.86
6.0
9.9
1.28
0.96
mmol/l
0.36
103
809
80
599
1.37
1.85
2.4
2.8
102.60
196.41
ng/l
3.32
74
545
28
168
1.69
1.82
1.1
1.4
—
—
—
0
0
32
200
1.62
1.79
2.4
2.2
0.00
0.00
g/l
-0.00
32
185
5
13
3.86
1.71
1.2
1.2
93.60
89.69
%
—
5
13
29
179
1.64
1.71
1.1
1.2
—
—
—
0
0
53
376
1.43
1.69
3.5
3.6
1.02
1.02
ratio
0.03
48
349
10
40
2.52
1.67
2.1
3.9
376.60
1009.70
u/ml
—
10
40
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
16
83
1.94
1.65
1.1
1.3
—
—
—
0
0
10
41
2.45
1.64
1.5
1.5
—
—
—
0
0
11
49
2.26
1.64
1.3
1.1
20.34
27.13
umol/l
0.28
11
42
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
821
7937
1.25
1.61
5.3
4.9
1.43
1.45
mmol/l
0.79
780
7380
34
224
1.54
1.56
1.6
1.4
161.59
267.22
ug/g
1.78
15
140
21
122
1.74
1.55
1.4
1.6
—
—
—
0
0
191
1635
1.21
1.55
1.7
1.7
420.99
30887060.90
pmol/l
1.69
170
1376
5
15
3.35
1.52
1.0
1.0
0.70
0.41
u/ml
—
5
15
5
15
3.35
1.52
1.0
1.4
11.99
7.98
ug/l
—
5
15
45
317
1.44
1.51
1.3
1.4
—
—
—
0
0
31
202
1.55
1.50
2.1
2.7
11.17
11.20
mg/l
0.01
31
183
12
58
2.08
1.49
1.5
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
37
2.45
1.48
1.0
1.2
—
—
—
0
0
40
278
1.46
1.44
2.2
2.3
2.72
2.83
g/l
0.37
40
255
28
180
1.57
1.44
1.1
1.2
—
—
—
0
0
42
296
1.44
1.42
2.2
2.3
3.70
3.50
g/l
0.51
42
272
42
296
1.44
1.42
2.2
2.3
7.39
7.14
g/l
0.46
42
272
9
40
2.26
1.40
1.0
1.3
11.67
11.15
mm/h
—
9
40
7
29
2.42
1.39
1.0
1.1
14.14
16.83
u/l
—
7
23
342
3107
1.16
1.37
5.4
5.1
1.99
2.93
ug/l
1.90
322
2822
9
42
2.15
1.34
1.3
1.2
—
—
—
0
0
145
1227
1.21
1.33
1.6
1.6
1317.51
1167.52
nmol/l
0.76
111
945
12
61
1.98
1.33
1.3
1.5
—
—
—
0
0
19
114
1.68
1.29
1.2
1.3
4.50
7.89
u/ml
—
6
35
97
790
1.25
1.28
2.5
2.5
30.76
41.02
u/l
2.14
78
672
6
25
2.41
1.24
1.2
1.0
90.17
87.20
%
—
6
20
8
36
2.23
1.24
1.0
1.1
—
—
—
0
0
41
296
1.40
1.24
2.2
2.3
4.20
4.19
g/l
0.02
41
273
133
1125
1.21
1.24
1.7
1.4
—
—
—
0
0
121
1015
1.22
1.22
1.9
1.8
1.48
1.49
%
0.03
104
892
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
76
943
0.79
1.19
2.3
2.1
3.73
3.52
ratio
0.58
59
753
278
2512
1.15
1.18
4.3
4.3
22.44
22.01
%
0.16
121
1244
781
7568
1.18
1.17
4.5
4.2
1.38
1.31
mmol/l
1.71
733
6985
373
3441
1.14
1.16
1.9
1.9
1.47
1.38
mmol/l
0.98
320
2887
29
199
1.47
1.15
4.5
3.3
0.78
2.46
index
2.21
18
109
5
20
2.51
1.15
1.2
2.0
—
—
—
0
0
67
531
1.28
1.12
1.8
1.9
—
—
—
0
0
163
1420
1.18
1.11
3.1
3.8
0.80
0.82
mmol/l
1.10
155
1360
34
243
1.41
1.11
1.3
1.9
—
—
—
0
0
211
1880
1.16
1.08
3.4
3.0
0.68
0.79
ug/l
0.97
129
1178
31
219
1.43
1.08
1.7
2.0
1.72
4.08
iu/l
—
10
97
7
33
2.13
1.05
1.4
1.2
—
—
—
0
0
7
33
2.13
1.05
1.4
1.2
—
—
—
0
0
7
33
2.13
1.05
1.4
1.2
—
—
—
0
0
25
170
1.48
1.05
1.3
1.5
—
—
—
0
0
11
60
1.84
1.03
1.5
1.1
97.91
112.77
pmol/l
0.30
11
60
12
68
1.77
1.00
1.1
1.1
—
—
—
0
0
17
107
1.60
1.00
1.0
1.2
120.88
115.70
%
0.28
17
96
18
115
1.58
1.00
1.1
1.1
—
—
—
0
0
60
479
1.27
0.97
3.2
3.9
24.79
24.02
mmol/l
1.21
60
470
107
910
1.20
0.97
7.5
6.7
—
—
—
0
0
0
30
0.00
0.97
0.0
1.1
—
4.27
—
0
25
7
36
1.95
0.97
3.6
10.8
—
63.94
—
0
16
30
217
1.39
0.94
1.3
1.7
—
—
—
0
0
7
37
1.90
0.94
1.1
1.2
111.57
617.23
u/l
—
7
31
7
37
1.90
0.94
1.1
1.4
—
—
—
0
0
23
324
0.70
0.90
1.6
1.8
2.49
6.00
mg/l
1.10
18
234
17
111
1.54
0.88
1.0
1.1
—
—
—
0
0
35
264
1.34
0.87
1.6
1.7
13.67
10.99
u/ml
—
9
76
6
30
2.01
0.87
1.0
1.1
79.17
71.84
u/l
—
6
25
6
31
1.94
0.84
1.7
2.3
48.00
51.42
umol/l
—
6
24
26
189
1.39
0.81
1.5
1.4
—
—
—
0
0
15
97
1.56
0.81
1.7
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
259
1.32
0.80
2.9
3.0
0.43
0.37
iu/ml
0.33
17
132
35
268
1.32
0.80
1.3
1.9
—
—
—
0
0
72
603
1.21
0.79
2.0
2.0
—
—
—
0
0
20
139
1.45
0.79
1.5
1.9
—
—
—
0
0
91
782
1.18
0.77
6.7
9.6
1.20
1.35
mmol/l
1.25
91
769
27
200
1.36
0.77
1.4
1.5
—
—
—
0
0
16
107
1.50
0.76
1.2
1.7
—
—
—
0
0
6
34
1.77
0.76
1.3
1.1
—
—
—
0
0
57
687
0.82
0.75
1.8
1.8
3.47
3.52
mmol/l
0.15
39
502
5
24
2.09
0.74
1.6
3.0
0.62
0.63
mmol/l
—
5
24
16
108
1.49
0.74
1.4
1.2
1.86
4.45
u/ml
—
7
49
7
38
1.85
0.73
1.4
1.1
—
—
—
0
0
39
308
1.28
0.73
2.2
1.9
—
—
—
0
0
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
9
56
1.61
0.72
1.2
1.8
—
—
—
0
0
13
84
1.56
0.72
1.1
1.1
—
—
—
0
0
37
291
1.28
0.72
2.3
2.6
—
—
—
0
0
12
76
1.59
0.72
2.5
2.6
—
—
—
0
0
16
109
1.48
0.71
1.1
1.2
—
—
—
0
0
28
212
1.33
0.71
1.3
1.3
—
—
—
0
0
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
47
385
1.23
0.66
1.1
1.0
—
—
—
0
0
15
103
1.46
0.65
1.9
2.5
32.80
32.11
pg
0.27
15
103
21
155
1.36
0.63
1.7
1.5
—
—
—
0
0
94
826
1.15
0.63
3.4
3.9
2.44
1.62
mmol/l
1.73
86
693
29
226
1.29
0.62
3.6
3.8
2.16
4.25
ratio
0.60
15
128
8
51
1.57
0.60
1.0
1.0
—
—
—
0
0
80
697
1.16
0.60
2.1
2.4
6.28
8.18
ug/l
0.40
72
620
32
254
1.27
0.60
2.4
2.4
94.19
89.31
%
0.57
32
245
15
105
1.44
0.60
1.1
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
301.14
—
0
14
32
255
1.26
0.58
2.2
1.9
—
—
—
0
0
8
53
1.51
0.58
1.0
4.9
78.38
116.53
nmol/l
—
8
53
6
35
1.72
0.57
1.8
1.2
—
—
—
0
0
6
35
1.72
0.57
1.8
1.2
—
—
—
0
0
102
909
1.14
0.57
3.8
5.0
55.72
24.29
ug/l
0.27
82
762
46
389
1.19
0.51
2.9
3.6
25.39
24.94
mmol/l
0.33
46
376
28
346
0.80
0.50
1.3
1.2
0.95
0.91
g/l
0.44
28
346
22
171
1.29
0.50
5.0
3.4
16.64
26.64
mg/l
1.90
11
114
26
323
0.80
0.49
1.2
1.1
0.74
0.66
ratio
—
7
46
7
45
1.56
0.49
1.7
1.3
0.75
1.31
nmol/l
—
7
33
7
109
0.64
0.48
1.1
1.1
—
—
—
0
0
7
46
1.53
0.48
1.3
1.7
—
—
—
0
0
11
76
1.45
0.48
4.2
3.9
9.00
12.07
index
—
6
55
7
47
1.49
0.47
1.7
1.7
—
—
—
0
0
7
47
1.49
0.47
1.3
1.7
—
—
—
0
0
39
329
1.19
0.45
1.7
2.0
1.88
1.37
ug/l
0.15
33
304
26
210
1.24
0.45
1.2
1.2
—
—
—
0
0
23
183
1.26
0.45
1.6
1.6
—
—
—
0
0
58
508
1.15
0.44
8.6
12.8
24.51
24.37
mmol/l
0.10
58
502
20
157
1.28
0.43
3.8
3.9
5.25
5.05
kpa
0.44
20
151
18
140
1.29
0.42
1.4
2.1
4.54
5.14
mmol/24h
0.43
18
123
10
70
1.43
0.42
1.9
1.6
—
—
—
0
0
8
58
1.38
0.41
1.9
1.4
16.38
14.49
u/l
—
8
53
5
33
1.52
0.41
2.2
2.7
—
—
—
0
0
28
336
0.83
0.40
1.3
1.2
1.53
1.54
g/l
0.07
28
336
0
17
0.00
0.40
0.0
1.3
—
1.17
—
0
17
17
132
1.29
0.40
1.8
1.6
—
—
—
0
0
28
233
1.21
0.39
1.2
1.3
—
—
—
0
0
9
70
1.29
0.36
1.2
1.7
—
—
—
0
0
9
70
1.29
0.36
1.1
1.3
—
—
—
0
0
5
78
0.64
0.35
1.2
1.5
—
—
—
0
0
5
78
0.64
0.35
1.2
1.5
—
—
—
0
0
5
78
0.64
0.35
1.2
1.5
—
—
—
0
0
26
219
1.19
0.33
1.6
1.6
—
—
—
0
0
6
87
0.69
0.33
1.0
1.5
—
—
—
0
0
6
87
0.69
0.33
1.0
1.5
—
—
—
0
0
6
87
0.69
0.33
1.0
1.5
—
—
—
0
0
6
89
0.67
0.33
1.0
1.4
—
—
—
0
0
6
90
0.66
0.33
1.0
1.4
—
—
—
0
0
10
132
0.75
0.32
3.2
2.8
9.84
7.62
u/ml
—
10
127
7
52
1.35
0.31
1.3
1.6
—
—
—
0
0
7
100
0.70
0.30
1.4
1.5
—
—
—
0
0
7
54
1.30
0.30
1.1
1.6
57.72
46.89
ug/l
—
7
54
27
232
1.17
0.29
1.3
1.8
276.78
323.05
mu/l
0.40
27
219
18
150
1.20
0.26
1.6
1.7
—
—
—
0
0
11
86
1.28
0.26
1.0
1.2
105.27
96.19
%
0.81
11
79
19
160
1.19
0.25
1.2
1.4
—
—
—
0
0
19
160
1.19
0.25
2.8
3.2
6.91
7.86
mmol/l
1.43
19
154
19
160
1.19
0.25
1.2
1.4
—
—
—
0
0
5
39
1.28
0.23
1.2
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
6.12
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
6.6
—
—
—
0
0
39
358
1.09
0.18
1.5
1.8
0.42
0.36
mg/l
0.22
22
182
5
70
0.71
0.16
1.6
1.8
—
—
—
0
0
7
90
0.78
0.14
1.0
1.4
—
—
—
0
0
24
218
1.10
0.13
1.3
1.3
188.00
269.39
miu/ml
0.38
11
95
92
950
0.97
0.10
5.0
4.8
32.04
32.21
%
0.04
68
612
54
516
1.05
0.10
1.2
1.2
168.50
138.86
u/ml
0.18
19
190
57
547
1.04
0.09
6.9
10.8
25.29
24.78
mmol/l
0.40
57
540
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
6
55
1.09
0.09
2.7
4.0
1.00
0.84
index
—
6
55
5
62
0.81
0.08
1.2
1.0
—
—
—
0
0
15
162
0.92
0.06
1.5
1.5
—
11.49
—
0
5
25
261
0.96
0.04
1.5
1.5
—
—
—
0
0
11
117
0.94
0.01
1.2
1.4
—
—
—
0
0
15
144
1.04
0.00
1.5
1.5
152.36
159.51
au/ml
—
5
46
27
276
0.98
0.00
1.6
1.6
—
—
—
0
0
10
96
1.04
0.00
1.2
1.8
—
—
—
0
0
17
174
0.98
0.00
1.4
1.5
1136.08
966.33
mu/l
0.25
12
144
37
366
1.01
0.00
3.1
3.8
75.44
10571.34
u/ml
0.82
29
323
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
7.64
—
0
5
5
57
0.88
-0.00
1.0
2.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
24.44
—
0
8
5
50
1.00
-0.00
1.0
1.0
1645.40
1635.76
miu/ml
—
5
50
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
-0.00
3.1
3.7
16.01
56.09
u/ml
—
7
72
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
—
—
0
0
9
90
1.00
-0.00
1.2
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_CARTILAGE and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_CARTILAGE | 1.362 [1.0, 1.85] | 0.05 |
| Birth year | 0.98 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 796 males with M13_CARTILAGE died.
Mortality risk
Mortality risk for people of age
years, who have M13_CARTILAGE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.249% |
| 5 | No data | 1.259% |
| 10 | No data | 3.205% |
| 15 | No data | 5.826% |
| 20 | No data | 9.971% |
Relationships between endpoints
↥Index endpoint: M13_CARTILAGE – Other articular cartilage disorders
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data